{
  "meta": {
    "title": "Late_Night_Pyq_Inicet_Medicine-5",
    "url": "https://brainandscalpel.vercel.app/late-night-pyq-inicet-medicine-5-7eb605d7.html",
    "scrapedAt": "2025-11-29T18:11:21.691Z"
  },
  "questions": [
    {
      "id": 54326,
      "choices": [
        {
          "id": 216773,
          "text": "<p><span style=\"font-size:12pt;\">Dapsone</span></p>"
        },
        {
          "id": 216774,
          "text": "<p><span style=\"font-size:12pt;\">Ofloxacin</span></p>"
        },
        {
          "id": 216775,
          "text": "<p><span style=\"font-size:12pt;\">Rifampicin</span></p>"
        },
        {
          "id": 216776,
          "text": "<p><span style=\"font-size:12pt;\">Clofazimine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following drugs used in the treatment of leprosy can result in hyperpigmentation?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q9163017",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115826,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Clofazimine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Clofazimine is a drug used in the treatment of leprosy that is known to cause hyperpigmentation as a side effect. This hyperpigmentation can affect the skin, resulting in a reddish-brown to nearly black discoloration. The effect is not limited to the skin; it can also cause discoloration of body fluids such as sweat and urine, potentially leading to staining of clothing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Dapsone:</strong> Incorrect as Dapsone, while used in leprosy treatment, is not typically associated with hyperpigmentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Ofloxacin:</strong> Incorrect because Ofloxacin, an antibiotic used in some leprosy treatment regimens, does not cause hyperpigmentation as a common side effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Rifampicin:</strong> Incorrect as Rifampicin, though it can cause orange-red discoloration of urine and other body fluids, is not associated with skin hyperpigmentation in the way clofazimine is.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Clofazimine, a drug used in leprosy treatment, can cause significant hyperpigmentation of the skin and discoloration of body fluids, which can be an important consideration in patient counseling and management.</span></p>",
      "correct_choice_id": 216776,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54326/INI-CET_May_2024Medicine_Question_71.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54326/INI-CET_May_2024Medicine_Question_71.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11805,
      "choices": [
        {
          "id": 47186,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iloprost</span></span></p>"
        },
        {
          "id": 47187,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ambrisentan</span></span></p>"
        },
        {
          "id": 47188,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nifedipine</span></span></p>"
        },
        {
          "id": 47189,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epoprostenol</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 35-year-old female patient with class II pulmonary hypertension presents with a negative vasoreactivity test. Which of the following is used in the next step of management? (INICET NOV 2021)</span></span></span></p>",
      "unique_key": "Q4761503",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115837,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Ambrisentan</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary arterial hypertension (PAH) management depends on the results of the vasoreactivity test. In patients with a negative vasoreactivity test, calcium channel blockers such as nifedipine are not effective. Instead, treatment typically involves the use of endothelin receptor antagonists, phosphodiesterase-5 inhibitors, or prostanoids.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For a patient with WHO functional class II PAH and a negative vasoreactivity test, the next step in management often includes endothelin receptor antagonists like Ambrisentan. Ambrisentan works by blocking the effects of endothelin-1, a potent vasoconstrictor, thereby reducing pulmonary vascular resistance and improving symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Iloprost:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Iloprost is a prostacyclin analog, used primarily in more advanced stages of PAH (class III or IV) or when other treatments have failed. It is not typically the first-line treatment for class II PAH with a negative vasoreactivity test.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Nifedipine:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Nifedipine, a calcium channel blocker, is used in patients with a positive vasoreactivity test. Since this patient has a negative vasoreactivity test, nifedipine is not appropriate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Epoprostenol:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Epoprostenol is another prostacyclin analog used in advanced PAH (class III or IV) or refractory cases. It is not typically used for initial treatment in class II PAH with a negative vasoreactivity test.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In class II and class III pulmonary arterial hypertension (PAH), the best option is to use a combination of a phosphodiesterase inhibitor like Tadalafil and an endothelin receptor antagonist like Ambrisentan. Combination therapy is preferred, even though it may not be listed in all options. For refractory class III and class IV PAH patients, prostanoids are used.</span></span></span></p>",
      "correct_choice_id": 47187,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54330,
      "choices": [
        {
          "id": 216789,
          "text": "<p><span style=\"font-size:12.0pt;\">Gonadal Dyagenesis</span></p>"
        },
        {
          "id": 216790,
          "text": "<p><span style=\"font-size:12.0pt;\">Mullerian Agenesis</span></p>"
        },
        {
          "id": 216791,
          "text": "<p><span style=\"font-size:12.0pt;\">Kallman Syndrome</span></p>"
        },
        {
          "id": 216792,
          "text": "<p><span style=\"font-size:12.0pt;\">Androgen insensitivity Syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">16-year-old girl presented with primary amenorrhea. On examination she has well developed secondary sexual characters and labs revealed a normal LH and FSH. Her karyotype is 46XX. What is the likely diagnosis?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q2545211",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115830,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Mullerian Agenesis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mullerian agenesis, also known as Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome, is the most likely diagnosis for this patient. The key features supporting this diagnosis are:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Primary amenorrhea in a 16-year-old girl</span></li><li><span style=\"font-size:12.0pt;\">Well-developed secondary sexual characters</span></li><li><span style=\"font-size:12.0pt;\">Normal LH and FSH levels</span></li><li><span style=\"font-size:12.0pt;\">46,XX karyotype</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In Mullerian agenesis, the uterus and upper vagina fail to develop properly, but the ovaries function normally. This explains the presence of secondary sexual characteristics and normal hormone levels, despite the absence of menstruation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Gonadal Dyagenesis:</strong> Incorrect because patients with gonadal dysgenesis typically have high FSH and LH levels due to lack of negative feedback from functioning gonads. They also often lack secondary sexual characteristics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Kallmann Syndrome:</strong> Incorrect, isolated GnRH deficiency which is characterized by</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">low LH and FSH levels, absent secondary sexual characteristics, and often associated with anosmia (loss of smell). The patient in this case has normal hormone levels and well-developed secondary sexual characteristics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Androgen Insensitivity Syndrome</strong>: Incorrect because this condition has a 46,XY karyotype, not 46,XX as in this case. Additionally, individuals with complete AIS would present with female external genitalia but lack a uterus and ovaries.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mullerian agenesis (MRKH syndrome) presents with primary amenorrhea, normal secondary sexual characteristics, normal hormone levels (LH and FSH), and a 46,XX karyotype.</span></p>",
      "correct_choice_id": 216790,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54330/INI-CET_May_2024Medicine_Question_75.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54330/INI-CET_May_2024Medicine_Question_75.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54306,
      "choices": [
        {
          "id": 216693,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary Pulmonary Artery Hypertension</span></p>"
        },
        {
          "id": 216694,
          "text": "<p><span style=\"font-size:12.0pt;\">Obstructive Sleep Apnea</span></p>"
        },
        {
          "id": 216695,
          "text": "<p><span style=\"font-size:12.0pt;\">Unstable Angina</span></p>"
        },
        {
          "id": 216696,
          "text": "<p><span style=\"font-size:12.0pt;\">Erectile Dysfunction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Inhaled NO is used in:</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q8780668",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115806,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Primary Pulmonary Artery Hypertension</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Inhaled nitric oxide (NO) is a potent pulmonary vasodilator used primarily in the management of various conditions associated with elevated pulmonary artery pressures. Its primary uses include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Primary Pulmonary Artery Hypertension (A):</strong> Inhaled NO is used to reduce pulmonary artery pressures and right ventricular afterload in patients with primary pulmonary hypertension. It helps improve oxygenation and reduce symptoms associated with this condition.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Acute Pulmonary Embolism:</strong> Inhaled NO can be used to lower pulmonary pressures and relieve right ventricular strain.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Pulmonary Arterial Hypertension (PAH):</strong> Inhaled NO is used for vasoreactivity testing and to manage secondary forms of PAH.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Right Ventricular Failure in STEMI:</strong> Particularly in inferior STEMI with right ventricular myocardial infarction (RVMI), inhaled NO can reduce right ventricular afterload.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Refractory Acute Respiratory Distress Syndrome (ARDS):</strong> Used as a bridging therapy to improve oxygenation until a more definitive treatment, such as lung transplantation, is available.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Obstructive Sleep Apnea:</strong> This condition is typically managed with continuous positive airway pressure (CPAP) therapy and lifestyle modifications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Unstable Angina:</strong> Managed with anti-anginal medications, antiplatelet therapy, and revascularization procedures as needed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Erectile Dysfunction:</strong> Treated with phosphodiesterase type 5 inhibitors (e.g., sildenafil), hormone therapy, or mechanical devices.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Inhaled nitric oxide is primarily used to manage conditions with elevated pulmonary artery pressures, such as primary pulmonary artery hypertension. It is not used for obstructive sleep apnea, unstable angina, or erectile dysfunction.</span></p>",
      "correct_choice_id": 216693,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54306/INI-CET_May_2024Medicine_Question_51.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54306/INI-CET_May_2024Medicine_Question_51.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54313,
      "choices": [
        {
          "id": 216721,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2</span></p>"
        },
        {
          "id": 216722,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4</span></p>"
        },
        {
          "id": 216723,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3</span></p>"
        },
        {
          "id": 216724,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is/are the complications associated with GERD?</span>&nbsp;(INICET MAY 2024)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Asthma</span></li><li><span style=\"font-size:12.0pt;\">Laryngitis</span></li><li><span style=\"font-size:12.0pt;\">Pulmonary Fibrosis</span></li><li><span style=\"font-size:12.0pt;\">Chronic cough</span></li></ol>",
      "unique_key": "Q9354568",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115813,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>D) 1, 2, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Gastroesophageal reflux disease (GERD) is a chronic condition where stomach contents flow back into the esophagus, causing various symptoms and complications. The complications of GERD can extend beyond the esophagus, affecting the respiratory system and other areas.</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Asthma:</strong> GERD can exacerbate asthma symptoms. The reflux of stomach acid can irritate the airways and lungs, triggering asthma attacks or making existing asthma more difficult to control.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Laryngitis:</strong> Acid reflux can lead to inflammation of the larynx (voice box), causing laryngitis. Symptoms may include hoarseness, throat pain, and voice changes.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Pulmonary Fibrosis:</strong> Although less common, chronic aspiration of gastric contents due to GERD can contribute to the development of pulmonary fibrosis. This is particularly seen in patients with diffuse scleroderma, where severe GERD is a significant risk factor for interstitial lung disease (ILD).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Chronic cough:</strong> GERD is a recognized cause of chronic cough. The reflux of acid can irritate the esophagus and respiratory tract, leading to a persistent cough.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">GERD can lead to a variety of extra-esophageal complications, including asthma, laryngitis, pulmonary fibrosis, and chronic cough. Recognizing these complications is crucial for the comprehensive management of patients with GERD.</span></p>",
      "correct_choice_id": 216724,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54313/INI-CET_May_2024Medicine_Question_58.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54313/INI-CET_May_2024Medicine_Question_58.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11814,
      "choices": [
        {
          "id": 47222,
          "text": "<p><span style=\"font-size:12.0pt;\">Natalizumab</span></p>"
        },
        {
          "id": 47223,
          "text": "<p><span style=\"font-size:12.0pt;\">Ocrelizumab</span></p>"
        },
        {
          "id": 47224,
          "text": "<p><span style=\"font-size:12.0pt;\">Fingolimod</span></p>"
        },
        {
          "id": 47225,
          "text": "<p><span style=\"font-size:12.0pt;\">Alemtuzumab</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following drugs is preferred in the management of primary progressive multiple sclerosis? (INICET NOV 2021)</span></p>",
      "unique_key": "Q5965774",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115839,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Ocrelizumab</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ocrelizumab is the preferred drug for the management of primary progressive multiple sclerosis (PPMS). PPMS is a form of multiple sclerosis characterized by a gradual progression of neurological symptoms without relapses. The reference paragraph highlights that Ocrelizumab is the only drug that has been shown to be effective in treating PPMS based on recent clinical trials. Ocrelizumab is a monoclonal antibody that targets CD20-positive B cells, which are believed to play a significant role in the pathogenesis of multiple sclerosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.</strong> <strong>Natalizumab:</strong> This drug is used primarily for relapsing-remitting multiple sclerosis (RRMS). It works by inhibiting the migration of immune cells into the central nervous system, but it has not been shown to be effective in PPMS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Fingolimod:</strong> While Fingolimod is effective in treating RRMS, it is not the preferred treatment for PPMS. Fingolimod works by modulating sphingosine-1-phosphate receptors to prevent lymphocytes from reaching the central nervous system.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Alemtuzumab:</strong> This drug is used for RRMS and works by depleting circulating T and B lymphocytes. It has not been demonstrated to be effective in treating PPMS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ocrelizumab is the only drug currently shown to be effective in the management of primary progressive multiple sclerosis (PPMS).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Remember</strong> - The drug that has been shown to be effective in treating secondary progressive multiple sclerosis (SPMS) is Siponimod, which is a sphingosine-1-phosphate receptor agonist.</span></p>",
      "correct_choice_id": 47223,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50957,
      "choices": [
        {
          "id": 203369,
          "text": "<p><span style=\"font-size:12.0pt;\">First degree heart block</span></p>"
        },
        {
          "id": 203370,
          "text": "<p><span style=\"font-size:12.0pt;\">Third degree heart block</span></p>"
        },
        {
          "id": 203371,
          "text": "<p><span style=\"font-size:12.0pt;\">Wenckebach heart block</span></p>"
        },
        {
          "id": 203372,
          "text": "<p><span style=\"font-size:12.0pt;\">Mobitz type 2 block</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">What is the diagnosis in the ECG shown below?(</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-112639.png\" alt=\"\" width=\"300\" height=\"90\"></span></p>",
      "unique_key": "Q9534440",
      "question_audio": null,
      "question_video": null,
      "map_id": 35116686,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Mobitz type 2 block</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The ECG shows bradycardia with regular, constant PR intervals in the conducted beats and intermittently dropped QRS complexes, which are indicative of Mobitz type 2 block. This type of atrioventricular block is characterized by:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Constant PR interval in the conducted beats</span></li><li><span style=\"font-size:12.0pt;\">Intermittent non-conducted P waves (dropped QRS complexes)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This distinguishes Mobitz type 2 block from other types of heart block:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. First degree heart block:&nbsp;</strong>Characterized by a prolonged PR interval (&gt;200 ms) but all P waves are followed by QRS complexes. This is not observed in the given ECG.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Third degree heart block</strong>: Complete dissociation between P waves and QRS complexes, with no relationship between them. The given ECG does not show this pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Wenckebach heart block (Mobitz type 1):&nbsp;</strong>Progressive prolongation of the PR interval until a QRS complex is dropped. The given ECG shows constant PR intervals, not progressively increasing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mobitz type 2 block is identified by a constant PR interval with intermittently non-conducted P waves. Recognizing this pattern is crucial for appropriate management, as Mobitz type 2 can progress to complete heart block and often requires a pacemaker.</span></p>",
      "correct_choice_id": 203372,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50958,
      "choices": [
        {
          "id": 203373,
          "text": "<p><span style=\"font-size:12.0pt;\">Diet, Exercise, Lifestyle modification + Metoprolol&nbsp;</span></p>"
        },
        {
          "id": 203374,
          "text": "<p><span style=\"font-size:12.0pt;\">Diet, Exercise, Lifestyle modification&nbsp;</span></p>"
        },
        {
          "id": 203375,
          "text": "<p><span style=\"font-size:12.0pt;\">Diet + Prazosin&nbsp;</span></p>"
        },
        {
          "id": 203376,
          "text": "<p><span style=\"font-size:12.0pt;\">Diet, Exercise, Lifestyle modification + Amlodipine&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old man with a known history of diabetes mellitus presents with a BP of 150/90 and dizziness. What is the best way to manage this patient? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2023)</span></p>",
      "unique_key": "Q9820360",
      "question_audio": null,
      "question_video": null,
      "map_id": 35116687,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D)&nbsp;Diet, Exercise, Lifestyle modification + Amlodipine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For a 60-year-old patient with diabetes and hypertension (BP 150/90 mmHg), it is critical to start pharmacological therapy along with lifestyle modifications to reduce cardiovascular risk. Current guidelines, including the 2023 European Society of Cardiology (ESC) guidelines, recommend initiating antihypertensive therapy in such patients due to the high risk of cardiovascular events. Amlodipine, a calcium channel blocker, is an appropriate choice for initial antihypertensive therapy in diabetic patients. It effectively lowers blood pressure and is well-tolerated, without negatively impacting glycemic control. Ideally, an ACE inhibitor or ARB would be preferred, but if not available, a calcium channel blocker like amlodipine is a suitable alternative.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Diet, Exercise, Lifestyle modification + Metoprolol</strong>: Metoprolol, a beta-blocker, is not first-line therapy for hypertension unless there is a specific indication such as coronary artery disease, heart failure, or angina. Beta-blockers are not the preferred initial treatment for hypertensive diabetics.</span></p><p><span style=\"font-size:10pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Diet, Exercise, Lifestyle modification:&nbsp;</strong>While lifestyle modifications are important, they are insufficient alone for managing hypertension in a diabetic patient, who is at high cardiovascular risk.</span></p><p><span style=\"font-size:10pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Diet + Prazosin:&nbsp;</strong>Prazosin, an alpha-blocker, is not typically used as first-line therapy for hypertension. It may be used in patients with benign prostatic hyperplasia (BPH) but offers no additional advantage in this context and may cause orthostatic hypotension, worsening dizziness.</span></p><p><span style=\"font-size:10pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For hypertensive diabetic patients, it is essential to start pharmacological therapy along with lifestyle modifications to reduce cardiovascular risk. Amlodipine is an appropriate choice for initial therapy in this context.</span></p>",
      "correct_choice_id": 203376,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11984,
      "choices": [
        {
          "id": 47901,
          "text": "<p><span style=\"font-size:12.0pt;\">Endoscopy</span></p>"
        },
        {
          "id": 47902,
          "text": "<p><span style=\"font-size:12.0pt;\">IgG antibody study</span></p>"
        },
        {
          "id": 47903,
          "text": "<p><span style=\"font-size:12.0pt;\">Urea breath test</span></p>"
        },
        {
          "id": 47904,
          "text": "<p><span style=\"font-size:12.0pt;\">Urease test of biopsy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient was treated for peptic ulcer with an H. pylori regimen. Which of the following is used to assess the success of treatment? (INICET NOV 2022)</span></p>",
      "unique_key": "Q4738135",
      "question_audio": null,
      "question_video": null,
      "map_id": 35116670,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. &nbsp;C) Urea breath test</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The urea breath test is the preferred non-invasive method to assess the success of H. pylori eradication therapy. It works by detecting the presence of urease, an enzyme produced by H. pylori. During the test, the patient ingests a urea solution labeled with a carbon isotope. If H. pylori is present, the urease enzyme breaks down the urea, releasing labeled carbon dioxide, which is then measured in the patient's breath. This test is highly accurate, non-invasive, and convenient for follow-up, making it the best choice for confirming the eradication of H. pylori after treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Endoscopy: </strong>While endoscopy with a biopsy for a rapid urease test can be used to detect H. pylori, it is invasive and not ideal for follow-up assessments when less invasive options are available.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. IgG antibody study: </strong>This test detects antibodies against H. pylori but is not useful for follow-up after treatment. Antibody levels can remain elevated for a long time even after the infection has been eradicated, leading to false-positive results.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Urease test of biopsy: </strong>This method, similar to endoscopy, involves an invasive procedure to obtain a gastric tissue sample for a rapid urease test. Although accurate, it is not preferred for follow-up due to its invasiveness compared to non-invasive options like the urea breath test.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The urea breath test is the preferred non-invasive method for assessing the success of H. pylori eradication therapy due to its accuracy and convenience.</span></p>",
      "correct_choice_id": 47903,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "InvestigationBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54327,
      "choices": [
        {
          "id": 216777,
          "text": "<p><span style=\"font-size:12.0pt;\">Hib vaccine</span></p>"
        },
        {
          "id": 216778,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatitis B vaccine</span></p>"
        },
        {
          "id": 216779,
          "text": "<p><span style=\"font-size:12.0pt;\">Meningococcal vaccine</span></p>"
        },
        {
          "id": 216780,
          "text": "<p><span style=\"font-size:12.0pt;\">Pneumococcal vaccine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a polysaccharide vaccine?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q8430313",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115827,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Hepatitis B vaccine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Hepatitis B vaccine is not a polysaccharide vaccine. It is a subunit vaccine containing surface antigen of the Hepatitis B virus. Polysaccharide vaccines are composed of long chains of sugar molecules that make up the surface capsule of certain bacteria. The Hepatitis B vaccine, in contrast, uses protein antigens from the virus's surface.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hib vaccine:</strong> This is a polysaccharide vaccine. It targets Haemophilus influenzae type b, a bacterium with a polysaccharide capsule.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Meningococcal vaccine:</strong> This is also a polysaccharide vaccine, designed to protect against Neisseria meningitidis, which has a polysaccharide capsule.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pneumococcal vaccine:</strong> This is a polysaccharide vaccine as well, targeting Streptococcus pneumoniae, another bacterium with a polysaccharide capsule.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">There are four main polysaccharide vaccines in practice, which can be remembered by the <strong>mnemonic \"SHINT\":</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Streptococcus pneumoniae (Pneumococcal),</span></li><li><span style=\"font-size:12.0pt;\">Haemophilus influenzae (Hib),</span></li><li><span style=\"font-size:12.0pt;\">Neisseria meningitidis (Meningococcal), and</span></li><li><span style=\"font-size:12.0pt;\">Typhoid (Salmonella typhi).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Hepatitis B vaccine is not part of this group as it's a subunit vaccine, not a polysaccharide vaccine.</span></p>",
      "correct_choice_id": 216778,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54327/INI-CET_May_2024Medicine_Question_72.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54327/INI-CET_May_2024Medicine_Question_72.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11872,
      "choices": [
        {
          "id": 47454,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Putamen</span></span></p>"
        },
        {
          "id": 47455,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Subthalamic nucleus</span></span></p>"
        },
        {
          "id": 47456,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Caudate nucleus</span></span></p>"
        },
        {
          "id": 47457,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Globus pallidus</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient presented with violent, flinging movements. Where is the lesion causing the hemiballismus seen? (INICET NOV 2022)</span></span></span></p>",
      "unique_key": "Q3909935",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115846,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Subthalamic nucleus</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hemiballismus is characterized by involuntary, violent, flinging movements, typically on one side of the body. This condition is most commonly associated with a lesion in the subthalamic nucleus. The subthalamic nucleus plays a crucial role in regulating movements, and damage to this area can lead to the excessive, uncontrolled movements seen in hemiballismus. This differentiates it from lesions in other parts of the basal ganglia, which are associated with different movement disorders.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Putamen:</span></strong><span style=\"font-size:12.0pt\"> Lesions in the putamen are more commonly associated with chorea, which involves rapid, involuntary, and irregular movements, rather than the violent flinging movements of hemiballismus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Caudate nucleus:</span></strong><span style=\"font-size:12.0pt\"> Similar to the putamen, lesions in the caudate nucleus typically result in chorea. The caudate nucleus is part of the striatum, and its dysfunction does not usually present with the violent movements characteristic of hemiballismus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Globus pallidus:</span></strong><span style=\"font-size:12.0pt\"> Lesions in the globus pallidus often result in athetosis, which involves slow, writhing movements. This is different from the abrupt and forceful movements seen in hemiballismus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hemiballismus, characterized by violent, flinging movements, is most commonly caused by a lesion in the subthalamic nucleus.</span></span></span></p>",
      "correct_choice_id": 47455,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11964,
      "choices": [
        {
          "id": 47821,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic alkalosis with high anion gap</span></p>"
        },
        {
          "id": 47822,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic acidosis with high anion gap</span></p>"
        },
        {
          "id": 47823,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic acidosis with normal anion gap</span></p>"
        },
        {
          "id": 47824,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic alkalosis with normal anion gap</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following electrolyte abnormalities is seen in methanol intoxication? (INICET NOV 2022)</span></p>",
      "unique_key": "Q1600804",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115853,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Metabolic acidosis with high anion gap</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Methanol intoxication leads to metabolic acidosis with a high anion gap &amp; high osmolal gap. Methanol is metabolized in the body to formic acid, which is a strong acid. The accumulation of formic acid in the bloodstream results in an increase in hydrogen ion concentration, leading to acidosis. The high anion gap indicates that there are unmeasured anions (such as formate) contributing to the acidosis. In addition to causing a high anion gap, methanol intoxication also leads to a high osmolal gap, which is another diagnostic clue in cases of toxic alcohol ingestion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Metabolic alkalosis with high anion gap:&nbsp;</strong>This statement is incorrect because methanol intoxication does not cause alkalosis. Instead, it causes acidosis due to the production of formic acid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Metabolic acidosis with normal anion gap:&nbsp;</strong>This statement is incorrect because the acidosis caused by methanol intoxication is characterized by a high anion gap due to the accumulation of formate, a byproduct of methanol metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Metabolic alkalosis with normal anion gap:&nbsp;</strong>This statement is incorrect because methanol intoxication leads to acidosis, not alkalosis, and the anion gap is elevated, not normal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Methanol intoxication causes metabolic acidosis with a high anion gap due to the accumulation of formic acid.</span></p>",
      "correct_choice_id": 47822,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11840,
      "choices": [
        {
          "id": 47326,
          "text": "<p><span style=\"font-size:12.0pt;\">Right Ventricle</span></p>"
        },
        {
          "id": 47327,
          "text": "<p><span style=\"font-size:12.0pt;\">Left Ventricle</span></p>"
        },
        {
          "id": 47328,
          "text": "<p><span style=\"font-size:12.0pt;\">Aorta</span></p>"
        },
        {
          "id": 47329,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitral Valve</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A chronic smoker presented with shortness of breath, bilateral pitting pedal edema, and abdominal distension. On examination, jugular venous pulse was found to be elevated and liver was palpable 8 cm below the costal margin. An abnormality in which of the following structures is responsible for the patient's symptoms? (INICET NOV 2021)</span></p>",
      "unique_key": "Q6078608",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115843,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Right Ventricle</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient’s presentation is characteristic of <strong>right ventricular failure</strong>, often secondary to chronic obstructive pulmonary disease (COPD) in chronic smokers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Key clinical features include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Shortness of breath</strong>: A common symptom in both left and right heart failure but is notably worsened by right heart failure due to fluid overload.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Bilateral pitting pedal edema</strong>: Indicates fluid retention, a hallmark of right ventricular failure.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Abdominal distension</strong>: Often due to ascites, which is related to increased venous pressure.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Elevated jugular venous pulse (JVP)</strong>: Reflects increased central venous pressure due to right heart dysfunction.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Hepatomegaly (enlarged liver)</strong>: Due to congestion of blood in the liver secondary to increased venous pressure.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Right ventricular failure results from the right ventricle's inability to pump blood effectively to the lungs, leading to a backup of blood in the systemic venous system.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Left Ventricle</strong>: Left ventricular failure primarily causes pulmonary congestion and edema due to the backflow of blood into the lungs. Symptoms like shortness of breath would predominate without the systemic venous congestion (e.g., pedal edema, elevated JVP, hepatomegaly) seen in right ventricular failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Aorta</strong>: An aortic abnormality would not directly cause the combination of symptoms described. Issues with the aorta generally result in systemic hypertension, aortic aneurysm, or dissection, which have different clinical presentations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Mitral Valve</strong>: Mitral valve disease, particularly mitral stenosis or regurgitation, primarily affects the left atrium and ventricle, leading to pulmonary congestion and symptoms more indicative of left heart failure rather than the systemic congestion seen here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Right ventricular failure</strong> is characterized by systemic venous congestion, which manifests as elevated jugular venous pressure, pitting pedal edema, hepatomegaly, and abdominal distension. This condition is often seen in chronic smokers due to the impact of chronic obstructive pulmonary disease (COPD) on the heart.</span></p>",
      "correct_choice_id": 47326,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54320,
      "choices": [
        {
          "id": 216749,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">X-linked Agammaglobulinemia </span></span></span></p>"
        },
        {
          "id": 216750,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic Granulomatous Disease </span></span></span></p>"
        },
        {
          "id": 216751,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Severe Combined Immunodeficiency </span></span></span></p>"
        },
        {
          "id": 216752,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chediak-Higashi syndrome</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following presents with repeated catalase-positive infections?&nbsp;</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q8529304",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115820,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Chronic Granulomatous Disease</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic Granulomatous Disease (CGD) is characterized by repeated catalase-positive infections. The key feature here is the defective NADPH oxidase complex, most commonly due to mutations in the <strong>CYBB gene</strong>. This defect impairs the neutrophils&#39; ability to produce a respiratory burst, resulting in a killing defect. Patients can phagocytose organisms but cannot effectively kill them, leading to persistent and repeated infections. These infections often result in chronic pus formation, abscesses, and granulomas, which can cause obstructive symptoms in various organ systems.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>catalase-positive organisms</strong> commonly associated with CGD can be remembered using the <strong>mnemonic PACEBAT</strong>: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">P - Pseudomonas aeruginosa </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A - Staphylococcus aureus, Aspergillus, Actinomyces israeli </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">C - Corynebacterium, Candida </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">E - Enterobacteriaceae (e.g., E. coli) </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">B - Burkholderia cepacia complex </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A - Actinomyces israeli (repeated) </span></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">T - Tuberculosis (Mycobacterium tuberculosis)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">CGD is typically inherited in an X-linked recessive pattern, although autosomal recessive forms exist.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic Granulomatous Disease (CGD), which can be diagnosed with:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">NBT (Nitroblue Tetrazolium) test</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Dihydrorhodamine (DHR) test</span></strong><span style=\"font-size:12.0pt\">, a flow cytometry-based test.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. X-linked Agammaglobulinemia: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect because this condition is characterized by a lack of B cells and immunoglobulins, leading to bacterial infections but not specifically catalase-positive infections. It typically manifests after 4 months of age when maternal antibodies wane.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Severe Combined Immunodeficiency:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Incorrect as SCID involves defects in both T and B cells, causing severe infections early in life (within weeks of birth). While it can include both bacterial and fungal infections, it&#39;s not specifically associated with catalase-positive organisms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note - </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Severe combined immunodeficiency (SCID)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> can be <strong>caused </strong>by:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ADA deficiency (Adenosine Deaminase deficiency)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">RAG-1/2 deficiency (Recombination Activating Genes 1 and 2 deficiency)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Interleukin-2 receptor gamma (IL-2RG) deficiency</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Chediak-Higashi syndrome: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incorrect because although it involves repeated infections due to neutrophil function defects, it&#39;s primarily characterized by partial albinism, giant granules in leukocytes, and bleeding tendencies. It&#39;s not specifically associated with catalase-positive infections.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note - </span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chediak-Higashi Syndrome is due to <strong>LYST gene defect</strong> and presents with a classic triad:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oculocutaneous albinism</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Recurrent infections </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Neurological abnormalities</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Giant azurophilic granules within neutrophils</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> are a characteristic feature of <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chediak-Higashi Syndrome</span></strong>.</span> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic Granulomatous Disease is characterized by repeated catalase-positive infections due to defective NADPH oxidase complex, impacting the ability of phagocytes to kill ingested microorganisms.</span></span></span></p>",
      "correct_choice_id": 216750,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11972,
      "choices": [
        {
          "id": 47853,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3</span></p>"
        },
        {
          "id": 47854,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 4</span></p>"
        },
        {
          "id": 47855,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 4</span></p>"
        },
        {
          "id": 47856,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following types of headaches requires further evaluation? (INICET NOV 2022)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Headache for &gt; 4 hours</span></li><li><span style=\"font-size:12.0pt;\">Worst headache of life</span></li><li><span style=\"font-size:12.0pt;\">New-onset progressive headache</span></li><li><span style=\"font-size:12.0pt;\">Headache with blurring of vision</span></li></ol>",
      "unique_key": "Q6718845",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115855,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. &nbsp;C) 2, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Certain types of headaches can be indicative of serious underlying conditions and thus require further evaluation to rule out life-threatening or severe pathologies:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Worst headache of life:</strong> This is a classic description of a subarachnoid hemorrhage, which is a medical emergency. Patients experiencing this type of headache require immediate medical attention and thorough investigation, typically involving neuroimaging.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. New-onset progressive headache:</strong> Progressive headaches, especially those that are new in onset and occur in adults, raise concern for potential serious conditions such as brain tumors or other intracranial pathologies. These headaches warrant detailed medical evaluation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Headache with blurring of vision:</strong> This symptom combination suggests possible increased intracranial pressure, which can be associated with conditions like papilledema or optic neuritis. Such cases need prompt assessment to determine the cause and appropriate management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Headache for &gt; 4 hours:</strong> While a headache lasting more than four hours can be distressing, it is not necessarily indicative of a severe underlying condition. Such headaches could be primary headaches like tension-type headaches or migraines, which often do not require immediate further evaluation unless they have other alarming features.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Headaches described as the \"worst headache of life,\" new-onset progressive headaches, and headaches accompanied by blurring of vision require further medical evaluation to rule out serious conditions.</span></p>",
      "correct_choice_id": 47855,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11864,
      "choices": [
        {
          "id": 47422,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antihistone antibodies</span></span></p>"
        },
        {
          "id": 47423,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-dsDNA antibodies</span></span></p>"
        },
        {
          "id": 47424,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anticentromere antibodies</span></span></p>"
        },
        {
          "id": 47425,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antinuclear antibodies</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A young patient presents to the clinic with erythematous lesions over the exposed areas of the skin like hands, arms, chest, etc. She also complains of arthralgia and breathlessness. Which among the following antibodies will be useful in diagnosing this condition? (INICET NOV 2022)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/whatsapp-image-2024-09-13-at-103830-am.jpeg\" style=\"height:257px; width:300px\" /></p>",
      "unique_key": "Q8595702",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115844,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Anti-dsDNA antibodies</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient exhibits symptoms including erythematous lesions on sun-exposed areas of the skin, arthralgia, and breathlessness, which are characteristic of Systemic Lupus Erythematosus (SLE). The rash described is typical of an SLE rash and not dermatomyositis, which presents with rashes over the knuckles known as Gottron&#39;s papules.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For diagnosing SLE, anti-dsDNA antibodies are very useful due to their high specificity. Although their sensitivity is relatively low (30-50%), the specificity is very high (&gt;90-95%), making them reliable markers for confirming the diagnosis of SLE. Anti-dsDNA antibodies are also associated with disease activity in SLE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Antihistone antibodies:</span></strong><span style=\"font-size:12.0pt\"> These are primarily associated with drug-induced lupus erythematosus, not classic SLE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Anticentromere antibodies:</span></strong><span style=\"font-size:12.0pt\"> These are typically seen in limited forms of scleroderma, particularly CREST syndrome, and are not associated with SLE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Antinuclear antibodies (ANA):</span></strong><span style=\"font-size:12.0pt\"> While ANA is a good initial screening test for SLE due to its high sensitivity, it lacks specificity. ANA can be positive in a variety of autoimmune conditions, thus it is not as specific as anti-dsDNA antibodies for diagnosing SLE.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anti-dsDNA antibodies are highly specific for diagnosing Systemic Lupus Erythematosus (SLE), despite their moderate sensitivity.</span></span></span></p>",
      "correct_choice_id": 47423,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54273,
      "choices": [
        {
          "id": 216561,
          "text": "<p><span style=\"font-size:12.0pt;\">Pioglitazone</span></p>"
        },
        {
          "id": 216562,
          "text": "<p><span style=\"font-size:12.0pt;\">Sitagliptin</span></p>"
        },
        {
          "id": 216563,
          "text": "<p><span style=\"font-size:12.0pt;\">Glimepiride</span></p>"
        },
        {
          "id": 216564,
          "text": "<p><span style=\"font-size:12.0pt;\">Metformin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs used in the management of diabetes is associated with unexplained diarrhea?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q2343755",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115804,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Metformin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Metformin is a biguanide used as a first-line treatment for type 2 diabetes mellitus. One of the most common and significant side effects of metformin is gastrointestinal disturbances, particularly diarrhea. This side effect is due to the drug’s effect on the gastrointestinal tract, which can cause alterations in bowel habits, including watery diarrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pioglitazone:</strong> This drug is a thiazolidinedione and is not typically associated with diarrhea. Its side effects include fluid retention, weight gain, and an increased risk of bladder cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Sitagliptin:</strong> Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. While it can cause gastrointestinal side effects, it is more commonly associated with symptoms like indigestion, nausea, and bloating rather than diarrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Glimepiride:</strong> Glimepiride is a sulfonylurea and is generally not associated with diarrhea. Its side effects typically include hypoglycemia and weight gain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Metformin is commonly associated with unexplained diarrhea as a side effect, making it important for healthcare providers to monitor patients for this gastrointestinal disturbance when prescribing the medication.</span></p>",
      "correct_choice_id": 216564,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54273/INI-CET_May_2024Medicine_Question_18.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54273/INI-CET_May_2024Medicine_Question_18.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50953,
      "choices": [
        {
          "id": 203353,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute HBV infection in window period&nbsp;</span></p>"
        },
        {
          "id": 203354,
          "text": "<p><span style=\"font-size:12.0pt;\">Immune with recombinant HBV Vaccine&nbsp;</span></p>"
        },
        {
          "id": 203355,
          "text": "<p><span style=\"font-size:12.0pt;\">HBV infection in the remote past, completely recovered&nbsp;</span></p>"
        },
        {
          "id": 203356,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic HBV infection inactive carrier&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The blood investigation of a patient is given below. What is the probable diagnosis? (</span>INICET Nov 2023)</p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">HBsAg - NR,</span></li><li><span style=\"font-size:12.0pt;\">Anti HBs - NR,</span></li><li><span style=\"font-size:12.0pt;\">Anti HBc IgM - NR,</span></li><li><span style=\"font-size:12.0pt;\">Anti HBc total - positive,</span></li><li><span style=\"font-size:12.0pt;\">HBeAg - NR,</span></li><li><span style=\"font-size:12.0pt;\">Anti HBe – NR (NR – Non reactive)</span></li></ul>",
      "unique_key": "Q1615461",
      "question_audio": null,
      "question_video": null,
      "map_id": 35116682,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;C) HBV infection in the remote past, completely recovered</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's serological markers indicate the following:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">HBsAg - Non-Reactive (NR): This suggests that the patient is not currently infected with Hepatitis B.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Anti HBs - NR: Lack of antibodies against the Hepatitis B surface antigen suggests no current immunity from vaccination or recent infection.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Anti HBc IgM - NR: The absence of IgM antibodies against the core antigen indicates no recent acute infection.</span></li><li><span style=\"font-size:12.0pt;\">Anti HBc total - positive: Presence of total core antibodies (including IgG) indicates past exposure to the virus.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">HBeAg - NR: Absence of the e antigen suggests no active viral replication.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Anti HBe - NR: Absence of antibodies against the e antigen suggests no current or recent active infection.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given these markers, the most likely scenario is that the patient had a Hepatitis B infection in the past and has completely recovered. The presence of Anti HBc total (which is predominantly IgG) signifies past infection. In cases of remote past infection, anti-HBs antibodies may fall below detectable levels, although the patient still has immunity through memory B cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Acute HBV infection in window period:&nbsp;</strong>In the window period of acute HBV infection, Anti HBc IgM should be positive, which is not the case here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Immune with recombinant HBV Vaccine:&nbsp;</strong>Patients vaccinated against HBV typically have positive Anti HBs and negative Anti HBc total, as they have not been exposed to the virus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Chronic HBV infection inactive carrier:</strong>&nbsp;Chronic HBV infection requires the presence of HBsAg for more than six months. The absence of HBsAg rules out chronic infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The presence of Anti HBc total (predominantly IgG) with all other markers negative suggests a past HBV infection that has completely resolved.</span></p>",
      "correct_choice_id": 203355,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54312,
      "choices": [
        {
          "id": 216717,
          "text": "<p><span style=\"font-size:12.0pt;\">Administer lactulose and wait for stool passage</span></p>"
        },
        {
          "id": 216718,
          "text": "<p><span style=\"font-size:12.0pt;\">Perform endoscopy to assess for varices</span></p>"
        },
        {
          "id": 216719,
          "text": "<p><span style=\"font-size:12.0pt;\">Initiate treatment with thiamine and lorazepam</span></p>"
        },
        {
          "id": 216720,
          "text": "<p><span style=\"font-size:12.0pt;\">Administer chlordiazepoxide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old male with a history of chronic alcoholism presents to the emergency department with vomiting, altered sensorium, and hypotension. His last binge drinking episode was 7 days ago. An ultrasound reveals a small liver with coarse echotexture and mild portal vein dilation. Given these findings, what is the most appropriate next step in managing this patient?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q9994256",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115812,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Initiate treatment with thiamine and lorazepam</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a chronic alcoholic presenting with altered sensorium, vomiting, and hypotension, the most critical differential diagnosis to consider is Wernicke's encephalopathy. This condition is caused by thiamine deficiency and is a medical emergency. It must be treated promptly to prevent permanent brain damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Wernicke's Encephalopathy:</strong> It is characterized by the triad of ophthalmoplegia, ataxia, and confusion. However, not all patients present with the complete triad, and altered mental status may be the most prominent feature. Chronic alcoholism is a significant risk factor for thiamine deficiency.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Thiamine Administration:</strong> Immediate administration of thiamine is crucial before any glucose administration, as glucose can precipitate Wernicke's encephalopathy in thiamine-deficient patients.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Lorazepam:</strong> In patients with cirrhosis or liver dysfunction, lorazepam is preferred over long-acting benzodiazepines like chlordiazepoxide due to its safer hepatic profile.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Administer lactulose and wait for stool passage:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Lactulose is used to treat hepatic encephalopathy by reducing ammonia levels. However, in this patient, the more urgent concern is Wernicke's encephalopathy due to the presenting symptoms and chronic alcoholism history.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Perform endoscopy to assess for varices:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Endoscopy may be necessary to assess for varices, especially in a patient with signs of portal hypertension and liver cirrhosis. However, it is not the immediate next step in an emergency setting where the patient presents with altered sensorium and the primary concern is Wernicke's encephalopathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Administer chlordiazepoxide:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Chlordiazepoxide is a long-acting benzodiazepine used in alcohol withdrawal. However, this patient last drank 7 days ago, making withdrawal less likely the primary issue. Additionally, chlordiazepoxide is not recommended in patients with liver dysfunction due to its long half-life and risk of accumulation. Lorazepam or oxazepam, which have safer profiles in liver dysfunction, would be better choices if benzodiazepines are needed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a chronic alcoholic presenting with altered sensorium, the immediate administration of thiamine is crucial to treat potential Wernicke's encephalopathy. Lorazepam can be used for its safer hepatic profile if benzodiazepine administration is necessary. The focus should be on treating the most urgent and reversible conditions first.</span></p>",
      "correct_choice_id": 216719,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54312/INI-CET_May_2024Medicine_Question_57.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54312/INI-CET_May_2024Medicine_Question_57.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11960,
      "choices": [
        {
          "id": 47805,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rectum</span></span></p>"
        },
        {
          "id": 47806,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Colon</span></span></p>"
        },
        {
          "id": 47807,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Small intestine</span></span></p>"
        },
        {
          "id": 47808,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ileocecal junction</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">What is the most common site of abdominal tuberculosis? (INICET NOV 2022)</span></span></span></p>",
      "unique_key": "Q5610317",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115852,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Ileocecal junction</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The ileocecal junction is the most common site of abdominal tuberculosis. This area, which includes the terminal ileum and the beginning of the large intestine (cecum), is particularly susceptible to infection by Mycobacterium tuberculosis. The lymphoid tissue in this region provides a favorable environment for the bacteria to proliferate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Abdominal tuberculosis can present in two primary forms: <strong>hypertrophic and ulcerative. </strong>The hypertrophic form involves thickening of the intestinal wall, while the ulcerative form leads to the formation of ulcers. Clinically, differentiating abdominal tuberculosis from Crohn&#39;s disease can be challenging due to overlapping symptoms and similar radiologic findings. In some cases, empirical anti-tubercular therapy (ATP) may be initiated, with subsequent monitoring for clinical improvement to help distinguish between the two conditions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Rectum:</span></strong><span style=\"font-size:12.0pt\"> The rectum is not a common site for abdominal tuberculosis. Tuberculosis primarily affects the ileocecal region and less frequently involves other parts of the gastrointestinal tract.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Colon:</span></strong><span style=\"font-size:12.0pt\"> While tuberculosis can affect the colon, it is not the most common site. The ileocecal junction is more frequently involved in abdominal tuberculosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Small intestine:</span></strong><span style=\"font-size:12.0pt\"> Although the small intestine can be affected, the terminal ileum specifically, which is part of the ileocecal junction, is the most common site for tuberculosis within the small intestine.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most common site of abdominal tuberculosis is the ileocecal junction, particularly near the terminal ileum. This region&#39;s lymphoid tissue creates a favorable environment for Mycobacterium tuberculosis to proliferate.</span></span></span></p>",
      "correct_choice_id": 47808,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11809,
      "choices": [
        {
          "id": 47202,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4, and 5</span></p>"
        },
        {
          "id": 47203,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 5 only</span></p>"
        },
        {
          "id": 47204,
          "text": "<p><span style=\"font-size:12.0pt;\">3, 4, 5 only</span></p>"
        },
        {
          "id": 47205,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4, and 5 only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old female patient came to the outpatient department with complaints of neck swelling. She gives a history of weight loss and palpitations. On examination, she has exophthalmos and a diffusely enlarged thyroid gland. What are the essential investigations that should be done for the patient? (INICET NOV 2021)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Thyroid scan</span></li><li><span style=\"font-size:12.0pt;\">Fine needle aspiration cytology (FNAC)</span></li><li><span style=\"font-size:12.0pt;\">Thyroid function tests</span></li><li><span style=\"font-size:12.0pt;\">Ultrasound of neck</span></li><li><span style=\"font-size:12.0pt;\">Anti-thyroid antibody</span></li></ol>",
      "unique_key": "Q5537454",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115838,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 1, 3, 4, and 5 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation of neck swelling, weight loss, palpitations, exophthalmos, and a diffusely enlarged thyroid gland suggests hyperthyroidism, likely Graves' disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">FNAC is not recommended in this case because it does not provide additional diagnostic yield for Graves' disease, does not alter the treatment plan, and carries a risk of complications due to the gland's increased vascularity in Graves' disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The following investigations are essential:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1<strong>. Thyroid scan</strong>: A radioactive iodine uptake scan helps differentiate between diffuse uptake (indicative of Graves' disease) and nodular uptake (indicative of toxic multinodular goiter or Plummer's disease).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">3.<strong> Thyroid function tests</strong>: These are crucial as they provide information on the levels of thyroid hormones (T3, T4) and thyroid-stimulating hormone (TSH), helping confirm the diagnosis of hyperthyroidism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">4<strong>. Ultrasound of neck</strong>: This imaging modality helps assess the thyroid gland's structure and can reveal increased vascularity, which is characteristic of Graves' disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">5. <strong>Anti-thyroid antibody</strong>: Testing for antibodies, such as TSH receptor antibodies (TRAbs) or thyroid-stimulating immunoglobulins (TSI), is important for diagnosing autoimmune thyroid diseases like Graves' disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For a patient with clinical signs of hyperthyroidism and a diffusely enlarged thyroid gland, essential investigations include a thyroid scan, thyroid function tests, ultrasound of the neck, and anti-thyroid antibody tests. Fine needle aspiration cytology (FNAC) is not typically required in these cases.</span></p>",
      "correct_choice_id": 47205,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54317,
      "choices": [
        {
          "id": 216737,
          "text": "<p><span style=\"font-size:12.0pt;\">a &amp; b</span></p>"
        },
        {
          "id": 216738,
          "text": "<p><span style=\"font-size:12.0pt;\">c &amp; d</span></p>"
        },
        {
          "id": 216739,
          "text": "<p><span style=\"font-size:12.0pt;\">None of above</span></p>"
        },
        {
          "id": 216740,
          "text": "<p><span style=\"font-size:12.0pt;\">All of above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with an unknown blood group experiences trauma and is unstable, requiring an urgent blood transfusion. Which types of blood should be transfused?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(multiple choice)</span>&nbsp;(INICET MAY 2024)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">a. A+</span><br><span style=\"font-size:12.0pt;\">b. AB+</span><br><span style=\"font-size:12.0pt;\">c. O+</span><br><span style=\"font-size:12.0pt;\">d. O-</span></p>",
      "unique_key": "Q3827051",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115817,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) c &amp; d</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In emergency situations where a patient’s blood type is unknown and an urgent blood transfusion is required, the safest choice is to use blood that minimizes the risk of adverse reactions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Universal Donor:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>d. O- (O Negative):</strong> O negative blood is considered the universal donor for red blood cells because it lacks A, B, and Rh antigens, which means it can be safely given to any patient regardless of their blood type. This is the safest option and is <strong>preferred</strong> when available.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>c. O+ (O Positive):</strong> In situations where O negative blood is not available, O positive blood can be used, especially in adult males and females beyond childbearing age, as it still minimizes the risk of severe hemolytic reactions. O positive blood can be safely given to any Rh-positive patient and is often used when O negative supplies are limited.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>a. A+:</strong> A positive blood can only be given to patients with A+ or AB+ blood types due to the presence of A antigens and the Rh factor, making it unsuitable for universal emergency transfusions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>b. AB+:</strong> AB positive blood is the universal recipient, meaning people with AB+ blood can receive any blood type, but it is not a universal donor. AB+ blood can only be given to other AB+ patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In emergency situations requiring urgent blood transfusions for patients with unknown blood types, O negative blood is the universal donor and the safest choice. If O negative is not available, O positive can also be used to minimize the risk of adverse reactions.</span></p>",
      "correct_choice_id": 216738,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54317/INI-CET_May_2024Medicine_Question_62.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54317/INI-CET_May_2024Medicine_Question_62.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11837,
      "choices": [
        {
          "id": 47314,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4 and 5</span></span></p>"
        },
        {
          "id": 47315,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3 and 5</span></span></p>"
        },
        {
          "id": 47316,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 and 2</span></span></p>"
        },
        {
          "id": 47317,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2 only</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 62-year-old male patient with heart failure is scheduled for a heart transplant. His renal function test is deranged, and hemoglobin is 6 g/dL. The physician ordered 2 units of whole blood. Four hours after transfusion, he developed severe respiratory distress. On examination, he is hypoxemic, has tachycardia, and his mean arterial pressure is elevated. Which of the following are the best investigations for the above scenario? (INICET NOV 2021)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chest X-ray</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Brain natriuretic peptide (BNP) level</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Absolute neutrophil count</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Leucocyte antibodies</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Platelets</span></span></span></li>\r\n</ol>",
      "unique_key": "Q6030204",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115842,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) 1 and 2</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient presents with signs and symptoms indicative of transfusion-associated circulatory overload (TACO), which includes elevated mean arterial pressure, hypoxemia, and respiratory distress following a blood transfusion. TACO occurs due to fluid overload from the transfusion, leading to pulmonary edema and increased cardiac filling pressures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">1. Chest X-ray</span></strong><span style=\"font-size:12.0pt\">: This imaging is crucial as it can reveal bilateral infiltrates indicative of pulmonary edema, a hallmark of TACO. It helps to differentiate between TACO and other causes of respiratory distress post-transfusion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">2. Brain Natriuretic Peptide (BNP) Level</span></strong><span style=\"font-size:12.0pt\">: BNP is a cardiac biomarker that is elevated in conditions of increased cardiac pressure and volume overload, such as TACO. Elevated BNP levels would support the diagnosis of TACO, whereas BNP levels would not be elevated in transfusion-related acute lung injury (TRALI), another potential complication post-transfusion that presents with respiratory distress but usually with hypotension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">3. </span></strong><span style=\"font-size:12.0pt\"><strong>Absolute neutrophil count </strong>and <strong>5.</strong> <strong>platelets </strong>are not specific for diagnosing TACO or TRALI. These parameters do not provide information on fluid overload or cardiac stress.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">4. </span></strong><span style=\"font-size:12.0pt\"><strong>Leucocyte antibodies </strong>are not directly relevant to the diagnosis of TACO. Leucocyte antibodies might be involved in TRALI, but not TACO.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For a patient with suspected transfusion-associated circulatory overload (TACO), the best investigations are a chest X-ray to detect pulmonary edema and BNP levels to assess cardiac stress and fluid overload</span></span></span></p>",
      "correct_choice_id": 47316,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54328,
      "choices": [
        {
          "id": 216781,
          "text": "<p><span style=\"font-size:12.0pt;\">Thick smear</span></p>"
        },
        {
          "id": 216782,
          "text": "<p><span style=\"font-size:12.0pt;\">Thin smear with acridine orange</span></p>"
        },
        {
          "id": 216783,
          "text": "<p><span style=\"font-size:12.0pt;\">Thin smear with Giemsa</span></p>"
        },
        {
          "id": 216784,
          "text": "<p><span style=\"font-size:12.0pt;\">Buffy Coat</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Best investigation for malaria speciation identification -</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q5230539",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115828,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Thin smear with Giemsa</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thin smear with Giemsa stain is the best method for malaria species identification. This technique provides a single layer of red blood cells (RBCs), allowing for clear visualization of the parasite's morphology. The Giemsa stain enhances the visibility of the parasite's features, making it easier to distinguish between different Plasmodium species based on their characteristic appearances within the RBCs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Thick smear:</strong> While useful for screening and detecting the presence of malaria parasites, thick smears contain multiple layers of RBCs and often deform the cells. This makes it difficult to accurately identify specific Plasmodium species.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Thin smear with acridine orange:</strong> This method, also known as the <strong>Kawamoto technique</strong>, stains only nucleic acids. While it highlights the parasites, it doesn't stain the RBCs, making it challenging to observe the parasite's relationship to the host cell and thus complicating species identification. (screening test)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Buffy Coat:</strong> This is a modified acridine orange-based test using a capillary tube instead of a slide. It's primarily a screening method to detect the presence of malaria parasites but is not suitable for species identification. (screening test)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thin blood smears stained with Giemsa are the gold standard for malaria species identification due to their ability to clearly show parasite morphology within a single layer of RBCs.</span></p>",
      "correct_choice_id": 216783,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54328/INI-CET_May_2024Medicine_Question_73.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54328/INI-CET_May_2024Medicine_Question_73.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54322,
      "choices": [
        {
          "id": 216757,
          "text": "<p><span style=\"font-size:12.0pt;\">FGF</span></p>"
        },
        {
          "id": 216758,
          "text": "<p><span style=\"font-size:12.0pt;\">PDGF</span></p>"
        },
        {
          "id": 216759,
          "text": "<p><span style=\"font-size:12.0pt;\">TGF alpha</span></p>"
        },
        {
          "id": 216760,
          "text": "<p><span style=\"font-size:12.0pt;\">TGF beta</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">&nbsp;All of the following are growth promoting proto-oncogenes except?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q8852457",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115822,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) TGF beta</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">TGF beta (Transforming Growth Factor beta) is the exception in this list as it is not a growth-promoting proto-oncogene. Instead, TGF beta is a classic example of a tumor suppressor protein. The TGF-beta/SMAD complex acts as a tumor suppressor complex, inhibiting cell growth and promoting apoptosis in normal cells. Loss of function mutations in the TGF-beta pathway can contribute to cancer development by removing this growth-inhibitory signal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. FGF (Fibroblast Growth Factor):</strong> FGF is indeed a growth-promoting proto-oncogene. It stimulates cell proliferation and survival in various cell types.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. PDGF (Platelet-Derived Growth Factor):</strong> PDGF is a growth-promoting proto-oncogene. It plays a crucial role in cell growth, division, and blood vessel formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. TGF alpha (Transforming Growth Factor alpha):</strong> TGF alpha is a growth-promoting proto-oncogene. It stimulates cell proliferation and is often overexpressed in various cancers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Among growth factors, TGF beta stands out as a tumor suppressor, while FGF, PDGF, and TGF alpha are growth-promoting proto-oncogenes. Understanding the distinct roles of these factors is crucial in comprehending cancer biology and developing targeted therapies.</span></p>",
      "correct_choice_id": 216760,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54322/INI-CET_May_2024Medicine_Question_67.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54322/INI-CET_May_2024Medicine_Question_67.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12002,
      "choices": [
        {
          "id": 47972,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Electrical alternans</span></span></p>"
        },
        {
          "id": 47973,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">P pulmonale</span></span></p>"
        },
        {
          "id": 47974,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ventricular bigeminy</span></span></p>"
        },
        {
          "id": 47975,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Improper calibration</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What does the ECG show? (INICET NOV 2022)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/whatsapp-image-2024-09-13-at-103852-am.jpeg\" style=\"height:209px; width:300px\" /></p>",
      "unique_key": "Q4702269",
      "question_audio": null,
      "question_video": null,
      "map_id": 35116674,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. &nbsp;B) P pulmonale</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The ECG presented shows tall P waves in lead II, which are characteristic of P pulmonale. P pulmonale refers to the presence of abnormally tall P waves in the ECG, usually greater than 2.5 mm in height in lead II. This finding indicates right atrial enlargement, which is commonly associated with pulmonary conditions such as pulmonary hypertension. Right atrial enlargement occurs due to increased pressure or volume overload in the right atrium, often secondary to lung diseases that lead to increased pulmonary artery pressures.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Electrical alternans:</span></strong><span style=\"font-size:12.0pt\"> Electrical alternans is characterized by alternating amplitude or direction of the QRS complexes in the ECG. It is often associated with large pericardial effusions and is not indicated by the tall P waves seen in this ECG.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Ventricular bigeminy:</span></strong><span style=\"font-size:12.0pt\"> Ventricular bigeminy refers to a rhythm where every normal beat is followed by a premature ventricular contraction (PVC). The ECG would show alternating normal QRS complexes with PVCs, which is not seen here.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Improper calibration:</span></strong><span style=\"font-size:12.0pt\"> Improper calibration of an ECG machine would result in uniformly abnormal waves across all leads, which does not match the specific tall P waves observed in lead II in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">P pulmonale, indicated by tall P waves greater than 2.5 mm in lead II, signifies right atrial enlargement commonly due to pulmonary hypertension or other pulmonary conditions leading to increased right atrial pressure.</span></span></span></p>",
      "correct_choice_id": 47973,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54316,
      "choices": [
        {
          "id": 216733,
          "text": "<p><span style=\"font-size:12.0pt;\">a &amp; c</span></p>"
        },
        {
          "id": 216734,
          "text": "<p><span style=\"font-size:12.0pt;\">a &amp; d</span></p>"
        },
        {
          "id": 216735,
          "text": "<p><span style=\"font-size:12.0pt;\">a, b, c</span></p>"
        },
        {
          "id": 216736,
          "text": "<p><span style=\"font-size:12.0pt;\">All of above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is used in the treatment of hemophilia B? (multiple choice)</span>&nbsp;(INICET MAY 2024)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">a) &nbsp;Fresh Frozen Plasma (FFP)</span><br><span style=\"font-size:12.0pt;\">b)&nbsp; Cryoprecipitate</span><br><span style=\"font-size:12.0pt;\">c) &nbsp;Factor VIII concentrates</span><br><span style=\"font-size:12.0pt;\">d) &nbsp;Cryo</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">poor Plasma</span></p>",
      "unique_key": "Q4585098",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115816,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) a &amp; d</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hemophilia B is a genetic bleeding disorder caused by a deficiency of factor IX. The primary treatment for hemophilia B involves the replacement of the missing factor IX.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Treatment Options:</strong> <strong>Factor IX concentrates:</strong> The specific treatment for hemophilia B is the administration of factor IX concentrates, which directly replace the deficient clotting factor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>a. Fresh Frozen Plasma (FFP):</strong> FFP contains all the clotting factors, including factor IX, in certain proportions. It can be used as a treatment for hemophilia B, especially in situations where factor IX concentrates are not available. FFP serves as a \"poor man's alternative\" due to its comprehensive content of clotting factors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>d. Cryopoor Plasma:</strong> This is FFP from which the cryoprecipitate has been removed. While cryoprecipitate contains high levels of factor VIII, von Willebrand factor, and fibrinogen, the cryopoor plasma retains significant amounts of factor IX. Therefore, cryopoor plasma can be used as an alternative treatment for hemophilia B. (<strong>preferred over FFP</strong>)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>b. Cryoprecipitate:</strong> This blood product is enriched with factor VIII, von Willebrand factor, and fibrinogen but contains little to no factor IX, making it unsuitable for treating hemophilia B.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>c. Factor VIII concentrates:</strong> This treatment is specific to hemophilia A, which is caused by a deficiency of factor VIII. It is not effective for hemophilia B.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The treatment of hemophilia B primarily involves the administration of factor IX concentrates. Fresh Frozen Plasma (FFP) and cryopoor plasma are also viable options due to their content of factor IX. Factor VIII concentrates and cryoprecipitate are not suitable for hemophilia B as they do not contain significant levels of factor IX.</span></p>",
      "correct_choice_id": 216734,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54316/INI-CET_May_2024Medicine_Question_61.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54316/INI-CET_May_2024Medicine_Question_61.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11885,
      "choices": [
        {
          "id": 47506,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemoperitoneum leads to reddish discoloration of the flanks of the abdomen.</span></p>"
        },
        {
          "id": 47507,
          "text": "<p><span style=\"font-size:12.0pt;\">Cullen’s sign refers to discoloration around the umbilicus.</span></p>"
        },
        {
          "id": 47508,
          "text": "<p><span style=\"font-size:12.0pt;\">Palpation begins at the site of pain.</span></p>"
        },
        {
          "id": 47509,
          "text": "<p><span style=\"font-size:12.0pt;\">Guarding and rigidity indicate peritoneal irritation.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with severe abdominal pain. Identify the false statement given about the examination of the abdomen: (INICET NOV 2022)</span></p>",
      "unique_key": "Q5384076",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115848,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Palpation begins at the site of pain.</strong></span></p><p><span style=\"font-size:11pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">Palpation in the examination of a patient with abdominal pain should never start at the site of pain. Instead, it should begin away from the painful area to avoid causing the patient unnecessary discomfort and to prevent muscle guarding that might obscure findings. This approach allows the examiner to gather information about the non-painful areas first and approach the painful site last, ensuring a more accurate and less distressing examination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hemoperitoneum leads to reddish discoloration of the flanks of the abdomen:&nbsp;</strong>This statement is correct. Hemoperitoneum, which is bleeding into the peritoneal cavity, can cause reddish or purplish discoloration on the flanks, known as Grey Turner’s sign. This is a significant indicator of internal bleeding, particularly in cases of acute pancreatitis or trauma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Cullen’s sign refers to discoloration around the umbilicus:&nbsp;</strong>This statement is correct. Cullen’s sign is the appearance of bluish discoloration around the umbilicus, which indicates intraperitoneal hemorrhage. It is often associated with conditions such as ruptured ectopic pregnancy or acute pancreatitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Guarding and rigidity indicate peritoneal irritation:&nbsp;</strong>This statement is correct. Guarding (voluntary or involuntary muscle contraction) and rigidity (a constant, board-like hardness of the abdominal muscles) are classic signs of peritoneal irritation or inflammation, such as that seen in peritonitis. These signs suggest that there may be an underlying acute inflammatory or infectious process in the abdomen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When examining a patient with abdominal pain, always begin palpation away from the site of pain to ensure a more accurate and less distressing assessment.</span></p>",
      "correct_choice_id": 47508,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11968,
      "choices": [
        {
          "id": 47837,
          "text": "<p><span style=\"font-size:12.0pt;\">Septic shock</span></p>"
        },
        {
          "id": 47838,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiogenic shock</span></p>"
        },
        {
          "id": 47839,
          "text": "<p><span style=\"font-size:12.0pt;\">Myxedema coma</span></p>"
        },
        {
          "id": 47840,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperthyroidism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 67-year-old woman presents with altered sensorium, breathlessness, hypotension, and bradycardia. Examination revealed non-pitting edema of the extremities. She has a long-standing history of weight gain, constipation, cold intolerance, and menorrhagia. What is the most likely diagnosis? (INICET NOV 2022)</span></p>",
      "unique_key": "Q9039936",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115854,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Myxedema coma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient presents with several symptoms indicative of severe hypothyroidism. These include altered sensorium, breathlessness, hypotension, bradycardia, non-pitting edema, weight gain, constipation, cold intolerance, and menorrhagia. In hypothyroid patients, a severe, life-threatening condition called myxedema coma can develop. This is characterized by a profound deficiency of thyroid hormones, leading to critical manifestations such as altered mental status, hypothermia, bradycardia, hypotension, and edema.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Myxedema coma requires immediate medical intervention. The treatment of choice involves intravenous administration of thyroxine (IV T4) and IV hydrocortisone. IV hydrocortisone is essential because many patients with myxedema coma have subtle adrenal insufficiency, which can become overt with the initiation of thyroid hormone replacement. This combination helps stabilize the patient's condition and addresses both thyroid and potential adrenal insufficiencies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Septic shock:</strong> While this condition involves hypotension and altered sensorium, it is usually associated with signs of infection, fever, and a source of sepsis, which are not described in this patient's presentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Cardiogenic shock:</strong> This condition involves heart failure and typically presents with signs of fluid overload, severe breathlessness, and possibly chest pain, none of which are noted in this patient’s history.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hyperthyroidism:</strong> The symptoms of hyperthyroidism include weight loss, heat intolerance, tachycardia, and increased bowel movements, which are opposite to the symptoms exhibited by this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Myxedema coma is a severe, life-threatening condition of profound hypothyroidism, characterized by symptoms such as altered sensorium, bradycardia, hypotension, and non-pitting edema. Immediate treatment involves IV thyroxine and IV hydrocortisone to manage both thyroid and potential adrenal insufficiency</span></p>",
      "correct_choice_id": 47839,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50948,
      "choices": [
        {
          "id": 203333,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Admit and give IV levofloxacin&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203334,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treat at home with oral Amox-clav </span></span></span></span></p>"
        },
        {
          "id": 203335,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Admit and give IV ceftriaxone&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203336,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Admit and give IV ceftriaxone and IV levofloxacin&nbsp;</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 65-year-old man was brought after a fall. He has a fever and confusion. On examination, he had a cough with rales. The patient was also tachypneic. How will you manage this patient? (</span></span>INICET Nov 2023)</p>",
      "unique_key": "Q2790895",
      "question_audio": null,
      "question_video": null,
      "map_id": 35116678,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Admit and give IV ceftriaxone and IV levofloxacin</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This patient is likely suffering from community-acquired pneumonia (CAP) and presents with confusion, fever, cough with rales, and tachypnea. Given his age (65 years) and symptoms, a CURB-65 score calculation is necessary. The CURB-65 score assigns points based on confusion, urea level, respiratory rate, blood pressure, and age &ge; 65. Here, the patient scores at least 3 points (confusion, tachypnea, age &ge; 65), indicating a need for hospital admission and potentially ICU care.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In managing CAP with a high CURB-65 score, empirical antibiotic therapy typically includes a combination of a beta-lactam (like ceftriaxone) and a macrolide or a respiratory fluoroquinolone (like levofloxacin). This combination is chosen to cover the most common pathogens, including Streptococcus pneumoniae and atypical bacteria.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Admit and give IV levofloxacin:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Levofloxacin alone is a potent respiratory fluoroquinolone but may not provide sufficient broad-spectrum coverage </span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Treat at home with oral Amox-clav:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Given the patient&#39;s high CURB-65 score, home treatment is inappropriate. Oral antibiotics like Amox-clav are insufficient for severe CAP needing hospitalization.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.&nbsp; Admit and give IV ceftriaxone:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While IV ceftriaxone is effective against many CAP pathogens, the addition of IV levofloxacin provides better coverage, especially for atypical organisms.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In elderly patients with high CURB-65 scores and suspected severe community-acquired pneumonia, hospital admission and combination antibiotic therapy (such as IV ceftriaxone and IV levofloxacin) are essential for effective management.</span></span></span></span></p>",
      "correct_choice_id": 203336,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11891,
      "choices": [
        {
          "id": 47529,
          "text": "<p><span style=\"font-size:12.0pt;\">Glimepiride</span></p>"
        },
        {
          "id": 47530,
          "text": "<p><span style=\"font-size:12.0pt;\">Exenatide</span></p>"
        },
        {
          "id": 47531,
          "text": "<p><span style=\"font-size:12.0pt;\">Vildagliptin</span></p>"
        },
        {
          "id": 47532,
          "text": "<p><span style=\"font-size:12.0pt;\">Linagliptin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with diabetes, hypertension, and chronic kidney disease has elevated serum creatinine and urea levels. Which of the following oral hypoglycemic agents is safe to use? (INICET NOV 2022)</span></p>",
      "unique_key": "Q9222152",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115850,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Linagliptin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Patients with chronic kidney disease (CKD) require careful selection of hypoglycemic agents due to altered drug excretion and the risk of further renal impairment. Among the given options, linagliptin is the safest choice for such patients. Linagliptin is a DPP-4 inhibitor that does not require dose adjustment in patients with renal impairment, including those on hemodialysis. This is because linagliptin is primarily excreted via the liver rather than the kidneys.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note –</strong> Certain GLP-1 receptor agonists like liraglutide, dulaglutide, and semaglutide can be used without dose adjustment according to the latest studies. Additionally, pioglitazone can also be used without dose adjustment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Glimepiride:</strong> This sulfonylurea can cause hypoglycemia and requires dose adjustment in patients with renal impairment, making it less suitable for those with elevated serum creatinine and urea levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Exenatide:</strong> This GLP-1 receptor agonist is contraindicated in patients with severe renal impairment (creatinine clearance &lt;30 mL/min) due to the risk of accumulation and potential toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Vildagliptin:</strong> Another DPP-4 inhibitor, vildagliptin requires dose adjustment in renal impairment, making it less favorable compared to linagliptin for patients with CKD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Linagliptin is the preferred oral hypoglycemic agent for patients with diabetes and chronic kidney disease, as it does not require dose adjustment and is safely excreted by the liver.</span></p><p>&nbsp;</p>",
      "correct_choice_id": 47532,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54310,
      "choices": [
        {
          "id": 216709,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2 and 4</span></p>"
        },
        {
          "id": 216710,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3 and 4</span></p>"
        },
        {
          "id": 216711,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2 and 3</span></p>"
        },
        {
          "id": 216712,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs are used for the treatment of cyanide poisoning?</span>&nbsp;(INICET MAY 2024)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Amyl nitrite</span></li><li><span style=\"font-size:12.0pt;\">Sodium nitrite</span></li><li><span style=\"font-size:12.0pt;\">Sodium thiosulfate</span></li><li><span style=\"font-size:12.0pt;\">Glyceryl trinitrate</span></li></ol>",
      "unique_key": "Q6813311",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115810,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 1, 2 and 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cyanide poisoning is a life-threatening condition that requires prompt treatment to prevent severe toxicity. The best treatment for cyanide poisoning is <strong>IV hydroxycobalamin (Vitamin B12)</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other alternative drugs are:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Amyl nitrite</strong>: This drug induces the formation of methemoglobin, which can bind cyanide ions and form cyanmethemoglobin, thereby preventing cyanide from inhibiting cytochrome oxidase enzymes.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Sodium nitrite</strong>: Similar to amyl nitrite, sodium nitrite also induces the formation of methemoglobin. This treatment is administered intravenously for more rapid effect compared to amyl nitrite.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Sodium thiosulfate</strong>: This acts as a sulfur donor, converting cyanide to the less toxic thiocyanate, which is then excreted in the urine. Sodium thiosulfate is often used in conjunction with nitrites to enhance cyanide detoxification.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other option:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Glyceryl trinitrate</strong>: This drug is primarily used in the management of angina and works as a vasodilator. It is not effective for the treatment of cyanide poisoning.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The primary drugs used for the treatment of cyanide poisoning are amyl nitrite, sodium nitrite, and sodium thiosulfate. Glyceryl trinitrate is not effective in this context.</span></p>",
      "correct_choice_id": 216711,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54310/INI-CET_May_2024Medicine_Question_55.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54310/INI-CET_May_2024Medicine_Question_55.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12008,
      "choices": [
        {
          "id": 47996,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Brown-Sequard syndrome</span></span></span></p>"
        },
        {
          "id": 47997,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tabes dorsalis</span></span></span></p>"
        },
        {
          "id": 47998,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Syringobulbia</span></span></span></p>"
        },
        {
          "id": 47999,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Syringomyelia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A female presented with loss of pain and temperature, but her touch sensation was intact. Imaging showed cavitation around the central canal. What is the probable diagnosis? (INICET NOV 2022)</span></span></span></p>",
      "unique_key": "Q5407363",
      "question_audio": null,
      "question_video": null,
      "map_id": 35116675,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. </span></strong><span style=\"font-size:12.0pt\">&nbsp;<strong>D) Syringomyelia</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Syringomyelia is characterized by the presence of a fluid-filled cavity or syrinx within the spinal cord, which typically expands over time. This condition most commonly affects the cervical and thoracic regions of the spinal cord. The classic presentation includes a loss of pain and temperature sensation in a &quot;cape-like&quot; distribution over the shoulders and back, while touch, vibration, and proprioception (posterior column sensations) remain intact. This pattern of sensory loss is due to the disruption of the decussating (crossing) fibers of the spinothalamic tract, which carry pain and temperature sensations. The cavitation around the central canal of the spinal cord is a hallmark of syringomyelia and leads to the aforementioned symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Brown-Sequard syndrome: </span></strong><span style=\"font-size:12.0pt\">This condition results from hemisection or damage to one half of the spinal cord. It typically presents with ipsilateral motor loss and loss of proprioception and vibration sense, and contralateral loss of pain and temperature sensation below the level of the lesion. This does not match the described symptoms and imaging findings.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Tabes dorsalis: </span></strong><span style=\"font-size:12.0pt\">This is a late manifestation of neurosyphilis, characterized by degeneration of the dorsal columns of the spinal cord, leading to impaired proprioception and vibration sense, ataxia, and lightning pains. It does not cause cavitation around the central canal or the specific dissociated sensory loss seen in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Syringobulbia: </span></strong><span style=\"font-size:12.0pt\">This is a similar condition to syringomyelia but involves the brainstem (medulla oblongata) rather than the spinal cord. It presents with symptoms related to cranial nerve involvement such as dysphagia, dysarthria, and facial pain. The patient&#39;s symptoms and imaging findings are more consistent with syringomyelia, not syringobulbia</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Syringomyelia presents with a loss of pain and temperature sensation while preserving touch sensation, and is characterized by cavitation around the central canal of the spinal cord.</span></span></span></p>",
      "correct_choice_id": 47999,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50952,
      "choices": [
        {
          "id": 203349,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lifestyle modification and weight loss&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203350,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ursodeoxycholic acid and lifestyle modification&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203351,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lifestyle modifications and vitamin E&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203352,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pioglitazone and lifestyle modifications&nbsp;</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with a history of consumption of 2-3 drinks per week comes with complaints of right upper quadrant discomfort. He has grade 2 steatosis. His BMI was 29 kg/m&sup2; and AST and ALT levels were slightly elevated. What would you advise him?&nbsp;</span></span>(INICET Nov 2023)</p>",
      "unique_key": "Q5694344",
      "question_audio": null,
      "question_video": null,
      "map_id": 35116681,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lifestyle modification and weight loss</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: &nbsp;</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient is likely suffering from non-alcoholic fatty liver disease (NAFLD), specifically non-alcoholic steatohepatitis (NASH), given his history of minimal alcohol consumption, grade 2 steatosis, elevated BMI, and mildly elevated liver enzymes (AST and ALT). The cornerstone of treatment for NASH is lifestyle modification and weight loss. These interventions help reduce liver fat, inflammation, and fibrosis. No FDA-approved medications currently exist for the treatment of NASH; thus, lifestyle changes are the primary recommended approach.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Ursodeoxycholic acid and lifestyle modification:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ursodeoxycholic acid is used for primary biliary cholangitis, not NASH, and thus is not appropriate here.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Lifestyle modifications and vitamin E:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin E can be used off-label in non-diabetic patients with NASH but is not FDA-approved or considered first-line treatment. It can be considered but is secondary to lifestyle changes.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Pioglitazone and lifestyle modifications:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pioglitazone, along with other medications like metformin and GLP-1 receptor agonists, is sometimes used off-label for diabetic patients with NASH. However, it is not FDA-approved for NASH and should not be the first-line recommendation.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lifestyle modification and weight loss are the primary and most effective treatments for non-alcoholic steatohepatitis (NASH), as no FDA-approved medications are currently available for this condition.</span></span></span></span></p>",
      "correct_choice_id": 203349,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11801,
      "choices": [
        {
          "id": 47170,
          "text": "<p><span style=\"font-size:12.0pt;\">Regardless of ejection fraction and the type of heart failure, the 5-year mortality rate is around 50%.</span></p>"
        },
        {
          "id": 47171,
          "text": "<p><span style=\"font-size:12.0pt;\">Non-cardiovascular death is more in HFrEF as compared to HFpEF.</span></p>"
        },
        {
          "id": 47172,
          "text": "<p><span style=\"font-size:12.0pt;\">ACEi cause cough in 15% and angioedema in 1%.</span></p>"
        },
        {
          "id": 47173,
          "text": "<p><span style=\"font-size:12.0pt;\">AF is common in the elderly and is the cause of stroke in a quarter of stroke cases.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All are true regarding heart failure except: (INICET NOV 2021)</span></p>",
      "unique_key": "Q6756854",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115836,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Non-cardiovascular death is more in HFrEF as compared to HFpEF.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Non-cardiovascular death refers to mortality due to causes other than cardiovascular diseases, such as infections, accidents, or malignancies.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The majority of deaths in HFrEF (Heart Failure with reduced Ejection Fraction) are due to cardiovascular causes (85%), and only 15% are due to non-cardiovascular causes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In contrast, in HFpEF (Heart Failure with preserved Ejection Fraction), 60% of deaths are cardiovascular, and 40% are non-cardiovascular.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore, non-cardiovascular death is actually more prevalent in HFpEF patients compared to HFrEF patients, making option B incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Regardless of ejection fraction and the type of heart failure, the 5-year mortality rate is around 50%: </strong>This statement is correct. Both HFpEF and HFrEF patients have similar 5-year mortality rates, approximately 50%. This indicates that having a preserved ejection fraction does not necessarily correlate with a better long-term survival rate compared to reduced ejection fraction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>ACEi cause cough in 15% and angioedema in 1%: </strong>This statement is correct. Angiotensin-Converting Enzyme inhibitors (ACEi) are known to cause a persistent cough in about 15% of patients and angioedema, a more serious but less common side effect, in approximately 1% of patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>AF is common in the elderly and is the cause of stroke in a quarter of stroke cases: </strong>This statement is correct. Atrial Fibrillation (AF) is indeed common among elderly patients and is a significant cause of cardioembolic strokes, accounting for about 25% of such cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Non-cardiovascular deaths are more common in HFpEF patients compared to HFrEF patients.</span></p>",
      "correct_choice_id": 47171,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50945,
      "choices": [
        {
          "id": 203321,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Furosemide</span></span></p>"
        },
        {
          "id": 203322,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carvedilol</span></span></p>"
        },
        {
          "id": 203323,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Digoxin&nbsp; </span></span></p>"
        },
        {
          "id": 203324,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Captopril</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An old man presents with dyspnea and swelling of his feet. On examination, rales are heard and he is found to have an enlarged heart on chest x-ray. Which of the following will delay the progression?</span></span></span></span></p>",
      "unique_key": "Q3027186",
      "question_audio": null,
      "question_video": null,
      "map_id": 35116676,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Captopril </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Captopril, an ACE inhibitor, has been shown to improve survival and delay the progression of heart failure. ACE inhibitors like Captopril work by blocking the conversion of angiotensin I to angiotensin II, leading to vasodilation and reduced workload on the heart. This class of drugs is considered a cornerstone in the management of heart failure with reduced ejection fraction (HF-REF). The benefits of ACE inhibitors in heart failure are well-documented, including the 1992 study on Enalapril, which demonstrated its effectiveness as a gold standard treatment.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Furosemide:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A loop diuretic, Furosemide is effective in reducing symptoms of congestion and decreasing heart failure hospitalization rates but does not improve survival or delay disease progression.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Carvedilol:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;While Carvedilol, a non-selective beta-blocker, has mortality benefits and improves survival in heart failure patients, it is not preferred over ACE inhibitors as the first choice for delaying heart failure progression.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Digoxin:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;This medication can reduce symptoms and heart failure hospitalizations to some extent, particularly in advanced heart failure, but it does not delay disease progression or improve survival, as evidenced by trials like the DIG trial.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ACE inhibitors, such as Captopril, are essential in delaying the progression of heart failure and improving survival.</span></span></span></span></p>",
      "correct_choice_id": 203324,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11876,
      "choices": [
        {
          "id": 47470,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Caf&eacute; au lait spot</span></span></p>"
        },
        {
          "id": 47471,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medullary thyroid carcinoma</span></span></p>"
        },
        {
          "id": 47472,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parathyroid adenoma</span></span></p>"
        },
        {
          "id": 47473,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Optic nerve glioma</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is seen in MEN 2B syndrome? (INICET NOV 2022)</span></span></p>",
      "unique_key": "Q5603946",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115847,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Medullary thyroid carcinoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Multiple Endocrine Neoplasia type 2B (MEN 2B) is a genetic syndrome characterized by the presence of specific tumors and physical features. This syndrome is often referred to as &quot;Triple M syndrome&quot; because it commonly presents with three key features: mucosal neuromas, a marfanoid body habitus, and medullary thyroid carcinoma. In addition, pheochromocytomas may also occur.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Medullary thyroid carcinoma (MTC) is a type of thyroid cancer originating from the parafollicular cells (C cells) that produce calcitonin. MTC is a hallmark of MEN 2B, making it one of the primary diagnostic criteria for the syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The condition is associated with mutations in the RET proto-oncogene, specifically the codon 918 mutation on chromosome 10, which leads to the development of these tumors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Caf&eacute; au lait spot:</span></strong><span style=\"font-size:12.0pt\"> Caf&eacute; au lait spots are not characteristic of MEN 2B syndrome. These pigmented skin lesions are more commonly associated with neurofibromatosis type 1 (NF1) and, in some cases, tuberous sclerosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Parathyroid adenoma:</span></strong><span style=\"font-size:12.0pt\"> Parathyroid adenomas are typically seen in patients with MEN 1 and MEN 2A syndromes, not in MEN 2B. These adenomas cause hyperparathyroidism, which is not a feature of MEN 2B.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Optic nerve glioma:</span></strong><span style=\"font-size:12.0pt\"> Optic nerve gliomas are primarily associated with neurofibromatosis type 1 (NF1). They are not a feature of MEN 2B syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most significant feature of MEN 2B syndrome is the presence of medullary thyroid carcinoma, alongside mucosal neuromas and a marfanoid body habitus, often linked to mutations in the RET proto-oncogene</span></span></span></p>",
      "correct_choice_id": 47471,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11794,
      "choices": [
        {
          "id": 47142,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urinary sodium &lt;20 mEq/L</span></span></p>"
        },
        {
          "id": 47143,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serum sodium &lt;135 mEq/L</span></span></p>"
        },
        {
          "id": 47144,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urine osmolality &gt;100 mOsm/kg</span></span></p>"
        },
        {
          "id": 47145,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patient can be clinically euvolemic</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following is not true about the syndrome of inappropriate antidiuretic hormone secretion (SIADH)? (INICET NOV 2021)</span></span></span></p>",
      "unique_key": "Q1536594",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115833,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Urinary sodium &lt;20 mEq/L</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The syndrome of inappropriate antidiuretic hormone secretion (SIADH) is characterized by the excessive release of antidiuretic hormone (ADH) from the posterior pituitary gland or another source. This excessive release results in water retention and <strong>dilutional hyponatremia.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Urinary sodium &lt;20 mEq/L</span></strong><span style=\"font-size:12.0pt\">: This option is incorrect. In SIADH, urinary sodium is typically high, usually greater than 40 mEq/L, due to the body&#39;s inability to excrete water appropriately, which leads to concentrated urine with high sodium levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Serum sodium &lt;135 mEq/L</span></strong><span style=\"font-size:12.0pt\">: This option is correct as SIADH commonly presents with hyponatremia (low serum sodium levels) due to the dilution of blood sodium by the retained water.</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Urine osmolality &gt;100 mOsm/kg</span></strong><span style=\"font-size:12.0pt\">: This option is correct. In SIADH, urine osmolality is typically high because the kidneys are concentrating the urine inappropriately due to the persistent effect of ADH.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Patient can be clinically euvolemic</span></strong><span style=\"font-size:12.0pt\">: This option is correct. Patients with SIADH often appear clinically euvolemic (normal body fluid volume), as the retained water is distributed evenly throughout the body without significant signs of fluid overload.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The key fact to remember is that in SIADH, patients have <strong>high urinary sodium (typically &gt;40 mEq/L)</strong> due to the body&#39;s inability to excrete water properly, leading to concentrated urine.</span></span></span></p>",
      "correct_choice_id": 47142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50950,
      "choices": [
        {
          "id": 203341,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3&nbsp;</span></p>"
        },
        {
          "id": 203342,
          "text": "<p><span style=\"font-size:12.0pt;\">4, 5&nbsp;</span></p>"
        },
        {
          "id": 203343,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4, 5&nbsp;</span></p>"
        },
        {
          "id": 203344,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old man presented with an acute onset of chest pain radiating to the left arm and diaphoresis. His ECG and cardiac biomarkers show non-ST elevation myocardial infarction. Which of the following will be used in the treatment of this patient? (</span>INICET Nov 2023)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. Atorvastatin&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">2. Aspirin&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">3. Clopidogrel&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">4. Low molecular weight heparin&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">5. Alteplase</span></p>",
      "unique_key": "Q9418706",
      "question_audio": null,
      "question_video": null,
      "map_id": 35116680,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D)&nbsp;1, 2, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the management of non-ST elevation myocardial infarction (NSTEMI), several medications are routinely used to reduce the risk of further ischemic events and manage the condition effectively:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Atorvastatin: High-intensity statin therapy is recommended to lower cholesterol levels and stabilize atherosclerotic plaques.</span></li><li><span style=\"font-size:12.0pt;\">Aspirin: This antiplatelet agent is essential for reducing clot formation and preventing further arterial blockage.</span></li><li><span style=\"font-size:12.0pt;\">Clopidogrel: Another antiplatelet agent, often used in combination with aspirin, to provide dual antiplatelet therapy (DAPT), which is beneficial in preventing further ischemic events.</span></li><li><span style=\"font-size:12.0pt;\">Low molecular weight heparin: Anticoagulant therapy, such as enoxaparin, is crucial in preventing thrombus formation and managing NSTEMI. Enoxaparin is typically administered subcutaneously at a dose of 1 mg/kg twice daily.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">5. Alteplase: This thrombolytic agent is used in the management of ST-elevation myocardial infarction (STEMI) when percutaneous coronary intervention (PCI) is not immediately available. It is not indicated for NSTEMI due to the lack of ST elevation and the associated risks of bleeding without significant benefit.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For NSTEMI management, the treatment includes Atorvastatin, Aspirin, Clopidogrel, and Low molecular weight heparin. Thrombolytic agents like Alteplase are reserved for STEMI with specific indications.</span></p>",
      "correct_choice_id": 203344,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11988,
      "choices": [
        {
          "id": 47917,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperresonance on percussion</span></span></p>"
        },
        {
          "id": 47918,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Coarse crackles</span></span></p>"
        },
        {
          "id": 47919,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dull note on percussion</span></span></p>"
        },
        {
          "id": 47920,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pleural rub</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient has a fever, cough, and cold. The chest X-ray is given below. What will be the examination finding in the infra-scapular region? (INICET NOV 2022)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/whatsapp-image-2024-09-13-at-103848-am.jpeg\" style=\"height:212px; width:300px\" /></p>",
      "unique_key": "Q7471954",
      "question_audio": null,
      "question_video": null,
      "map_id": 35116671,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Dull note on percussion</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s symptoms and the chest X-ray findings indicate pleural effusion. Key features of pleural effusion on a chest X-ray include the meniscus sign and blunting of the costophrenic angle. Clinically, pleural effusion leads to reduced or absent air entry in the affected area.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A dull note on percussion is a hallmark sign of pleural effusion. This occurs due to the accumulation of fluid in the pleural space, which does not transmit sound vibrations as efficiently as air-filled lung tissue.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Hyperresonance on percussion:</span></strong><span style=\"font-size:12.0pt\"> This finding is characteristic of pneumothorax, where there is an excess of air in the pleural space, leading to increased resonance.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Coarse crackles:</span></strong><span style=\"font-size:12.0pt\"> Coarse crackles can be heard in various conditions such as bronchiectasis</span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">, the resolving phase of pneumonia, or pulmonary edema. However, they are not typically associated with pleural effusion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Pleural rub:</span></strong><span style=\"font-size:12.0pt\"> Pleural rub is a sign of pleuritis or inflammation of the pleura. It is usually absent in pleural effusion due to the separation of pleural surfaces by fluid.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A dull note on percussion is a key clinical finding in pleural effusion, indicating the presence of fluid in the pleural space.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>",
      "correct_choice_id": 47919,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54315,
      "choices": [
        {
          "id": 216729,
          "text": "<p><span style=\"font-size:12.0pt;\">A-3, B-1, C-4, D-2</span></p>"
        },
        {
          "id": 216730,
          "text": "<p><span style=\"font-size:12.0pt;\">A-2, B-3, C-1, D-4</span></p>"
        },
        {
          "id": 216731,
          "text": "<p><span style=\"font-size:12.0pt;\">A-3, B-4, C-2, D-1</span></p>"
        },
        {
          "id": 216732,
          "text": "<p><span style=\"font-size:12.0pt;\">A-3, B-1, C-2, D-1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the blood product with the shelf life mentioned in the next column:</span>&nbsp;(INICET MAY 2024)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-134922.jpg\" alt=\"\" width=\"700\" height=\"380\"></span></p>",
      "unique_key": "Q3063389",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115815,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) A-3, B-1, C-4, D-2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The shelf lives of various blood products are crucial for ensuring their efficacy and safety in clinical use. Here is the matching of blood products with their respective shelf lives:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Single donor platelet (A)</strong>: These typically have a shelf life of <strong>5 days (3.)</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Packed red blood cells (B)</strong>: These can be stored for up to <strong>42 days</strong> depending on the preservative used (1.).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Cryoprecipitate (C)</strong>: This blood product has a shelf life of <strong>1 year</strong> when stored properly (4.).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Granulocyte concentrate (D)</strong>: This product has a short shelf life of <strong>24 hours (2.)</strong>.</span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The shelf life of different blood products is essential for proper storage and timely usage in medical practice.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Single donor platelet - 5 days</span></li><li><span style=\"font-size:12.0pt;\">Packed red blood cells - 42 days</span></li><li><span style=\"font-size:12.0pt;\">Cryoprecipitate - 1 year</span></li><li><span style=\"font-size:12.0pt;\">Granulocyte concentrate - 24 hours</span></li></ul>",
      "correct_choice_id": 216729,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54315/INI-CET_May_2024Medicine_Question_60.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54315/INI-CET_May_2024Medicine_Question_60.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50949,
      "choices": [
        {
          "id": 203337,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory acidosis, hyperventilation, inadequate metabolic compensation&nbsp;</span></p>"
        },
        {
          "id": 203338,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory alkalosis, hypoventilation, inadequate metabolic compensation&nbsp;</span></p>"
        },
        {
          "id": 203339,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory acidosis, hypoventilation, inadequate metabolic compensation&nbsp;</span></p>"
        },
        {
          "id": 203340,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory acidosis, hypoventilation, adequate metabolic compensation&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old with a history of COPD is brought to the ER with worsening dyspnea. ABG was done and pH was 7.3, pCO2 was 60 mmHg with HCO3- being 28 mEq/L. Which of the following is seen in this patient? (</span>INICET Nov 2023)</p>",
      "unique_key": "Q8761970",
      "question_audio": null,
      "question_video": null,
      "map_id": 35116679,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Respiratory acidosis, hypoventilation, inadequate metabolic compensation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's arterial blood gas (ABG) shows a pH of 7.3, indicating acidosis (normal pH: 7.35-7.45). The elevated pCO2 of 60 mmHg (normal: 35-45 mmHg) points to a respiratory cause of the acidosis, specifically respiratory acidosis. In COPD patients, chronic CO2 retention is common, leading to increased bicarbonate (HCO3-) levels as a compensatory mechanism. However, in acute respiratory acidosis, the metabolic compensation is typically inadequate, as seen by the HCO3- level of 28 mEq/L (normal: 22-28 mEq/L). The inadequate compensation suggests an acute exacerbation rather than a chronic condition, as chronic respiratory acidosis would have a more elevated bicarbonate level (&gt;30 mEq/L).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Respiratory acidosis, hyperventilation, inadequate</strong> <strong>metabolic compensation:</strong> Hyperventilation leads to respiratory alkalosis, not acidosis. The patient's presentation does not fit this scenario.</span></p><p><span style=\"font-size:10pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Respiratory alkalosis, hypoventilation, inadequate metabolic compensation:</strong>&nbsp;Hypoventilation causes respiratory acidosis, not alkalosis. This choice is incorrect.</span></p><p><span style=\"font-size:10pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Respiratory acidosis, hypoventilation, adequate metabolic compensation:&nbsp;</strong>Adequate metabolic compensation would show higher bicarbonate levels (&gt;30 mEq/L). The patient's bicarbonate level indicates inadequate compensation, ruling out this option.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In acute respiratory acidosis due to COPD exacerbation, expect hypoventilation and inadequate metabolic compensation, indicated by elevated pCO2 and only slightly elevated HCO3- levels.</span></p>",
      "correct_choice_id": 203339,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54311,
      "choices": [
        {
          "id": 216713,
          "text": "<p><span style=\"font-size:12.0pt;\">a, b &amp; c are correct</span></p>"
        },
        {
          "id": 216714,
          "text": "<p><span style=\"font-size:12.0pt;\">b &amp; c are correct</span></p>"
        },
        {
          "id": 216715,
          "text": "<p><span style=\"font-size:12.0pt;\">a, c &amp; d</span></p>"
        },
        {
          "id": 216716,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is/are criteria for anaphylaxis?</span>&nbsp;(INICET MAY 2024)</p><p>&nbsp;</p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\">Persistent abdominal cramps and vomiting</span></li><li><span style=\"font-size:12.0pt;\">Hypertension</span></li><li><span style=\"font-size:12.0pt;\">Urticaria and swollen lips</span></li><li><span style=\"font-size:12.0pt;\">Respiratory distress</span></li></ol>",
      "unique_key": "Q4790056",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115811,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) a, c &amp; d</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Anaphylaxis is a severe, potentially life-threatening allergic reaction that occurs rapidly and requires immediate medical attention. The diagnostic criteria for anaphylaxis typically involve the acute onset of symptoms affecting multiple organ systems.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>a. Persistent abdominal cramps and vomiting:</strong> These are gastrointestinal symptoms that can be part of anaphylaxis when present with other criteria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>c. Urticaria and swollen lips:</strong> These are common skin manifestations of anaphylaxis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>d. Respiratory distress:</strong> Respiratory compromise is a key feature of anaphylaxis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Diagnostic Criteria for Anaphylaxis (Acute onset – within minutes to hours)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Involvement of the skin, mucosal tissue + ≥ 1 of the following:</strong></span></p><p><span style=\"font-size:12.0pt;\">a. Respiratory compromise (e.g., dyspnea, wheeze-bronchospasm, stridor, hypoxemia)</span></p><p><span style=\"font-size:12.0pt;\">b. Hypotension or associated symptoms</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>≥ 2 of the following:</strong></span></p><p><span style=\"font-size:12.0pt;\">a. Involvement of the skin mucosal tissue</span></p><p><span style=\"font-size:12.0pt;\">b. Respiratory compromise</span></p><p><span style=\"font-size:12.0pt;\">c. Hypotension or associated symptoms</span></p><p><span style=\"font-size:12.0pt;\">d. Persistent GI symptoms</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reduced BP after exposure to known allergen:</strong></span></p><p><span style=\"font-size:12.0pt;\">A. Infants and children – Low SBP (adjusted to age) or &gt; 30% decrease in SBP</span></p><p><span style=\"font-size:12.0pt;\">B. Adults – SBP &lt; 90 mmHg or &gt; 30% decrease in SBP</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option b. Hypertension: </strong>Anaphylaxis is typically associated with hypotension, not hypertension. Hypotension is a significant marker for the severity of the reaction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Anaphylaxis is a severe allergic reaction that involves multiple organ systems and is characterized by symptoms such as urticaria, swollen lips, respiratory distress, and persistent gastrointestinal symptoms. Hypotension, rather than hypertension, is a critical diagnostic feature. Recognizing these criteria promptly is crucial for the immediate management of anaphylaxis.</span></p>",
      "correct_choice_id": 216715,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54311/INI-CET_May_2024Medicine_Question_56.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "CriteriaBased",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54311/INI-CET_May_2024Medicine_Question_56.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11833,
      "choices": [
        {
          "id": 47298,
          "text": "<p><span style=\"font-size:12.0pt;\">1-5% of the population can have epileptiform discharges.</span></p>"
        },
        {
          "id": 47299,
          "text": "<p><span style=\"font-size:12.0pt;\">Scalp EEG may be helpful in localizing frontal lobe epilepsy.</span></p>"
        },
        {
          "id": 47300,
          "text": "<p><span style=\"font-size:12.0pt;\">Doing EEG is mandatory for the diagnosis of seizures.</span></p>"
        },
        {
          "id": 47301,
          "text": "<p><span style=\"font-size:12.0pt;\">Progressive multifocal leukoencephalopathy shows triphasic and slow waves.</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">True about electroencephalogram (EEG) is all except: (INICET NOV 2021)</span></p>",
      "unique_key": "Q8403798",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115841,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Doing EEG is mandatory for the diagnosis of seizures.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Electroencephalography (EEG) is a key diagnostic tool in the evaluation of neurological conditions, particularly epilepsy. However, it is not mandatory for the diagnosis of seizures. A patient can have seizures even if their EEG results are normal. <strong>An abnormal EEG can provide reassurance of a diagnosis of epilepsy when the clinical context supports it, but a normal EEG does not rule out epilepsy or seizures.</strong> Therefore, making an EEG mandatory for the diagnosis of seizures is incorrect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>1-5% of the population can have epileptiform discharges: </strong>This statement is correct. Epileptiform discharges can be present in a small percentage of the general population without necessarily indicating that the individual has epilepsy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Scalp EEG may be helpful in localizing frontal lobe epilepsy: </strong>This statement is correct. Scalp EEG can indeed help localize the origin of epileptic activity, including frontal lobe epilepsy, although it might not always be definitive.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>.&nbsp;<strong>Progressive multifocal leukoencephalopathy shows triphasic and slow waves: </strong>This statement is correct. Progressive multifocal leukoencephalopathy (PML) and other forms of encephalopathy can show triphasic waves and slow wave patterns on an EEG.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">EEG is not mandatory for the diagnosis of seizures as patients can have seizures even with a normal EEG.</span></p>",
      "correct_choice_id": 47300,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11903,
      "choices": [
        {
          "id": 47577,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amlodipine</span></span></p>"
        },
        {
          "id": 47578,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Telmisartan</span></span></p>"
        },
        {
          "id": 47579,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metoprolol</span></span></p>"
        },
        {
          "id": 47580,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Olmesartan</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A hypertensive patient who is on losartan develops an HbA1c level of 8.1%. Which of the following drugs would you replace losartan with? (INICET NOV 2022)</span></span></span></p>",
      "unique_key": "Q1632809",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115851,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Telmisartan</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Telmisartan is the appropriate choice for a hypertensive patient with an elevated HbA1c level (8.1%), indicating poorly controlled diabetes. Telmisartan, an angiotensin II receptor blocker (ARB), has unique properties among ARBs due to its partial agonistic activity on peroxisome proliferator-activated receptor-gamma (PPAR-gamma). PPAR-gamma agonists can improve insulin sensitivity and have beneficial effects on glycemic control. This makes Telmisartan particularly useful for patients managing both hypertension and diabetes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Amlodipine:</span></strong><span style=\"font-size:12.0pt\"> Amlodipine is a calcium channel blocker used for hypertension. It does not have the beneficial effects on glycemic control seen with Telmisartan and would not be the preferred choice in a patient with elevated HbA1c.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Metoprolol:</span></strong><span style=\"font-size:12.0pt\"> Metoprolol is a beta-blocker. While effective for hypertension, beta-blockers can potentially worsen glycemic control and are not ideal for patients with diabetes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Olmesartan:</span></strong><span style=\"font-size:12.0pt\"> Olmesartan is another ARB, but unlike Telmisartan, it lacks PPAR-gamma agonistic activity. Thus, it does not offer the additional benefit of improving insulin sensitivity and glycemic control.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For hypertensive patients with diabetes and elevated HbA1c levels, Telmisartan is the preferred replacement for losartan due to its PPAR-gamma agonistic activity, which helps improve glycemic control.</span></span></span></p>",
      "correct_choice_id": 47578,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54257,
      "choices": [
        {
          "id": 216497,
          "text": "<p><span style=\"font-size:12.0pt;\">Synchronized DC Cardioversion</span></p>"
        },
        {
          "id": 216498,
          "text": "<p><span style=\"font-size:12.0pt;\">IV Adenosine (6mg)</span></p>"
        },
        {
          "id": 216499,
          "text": "<p><span style=\"font-size:12.0pt;\">Carotid Sinus Massage</span></p>"
        },
        {
          "id": 216500,
          "text": "<p><span style=\"font-size:12.0pt;\">IV Amiodarone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young male presented with palpitations and hence ECG was taken. ECG demonstrated narrow complex tachycardia and his BP was 70/40 mm of Hg. What is the next step in the management of this patient?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q2712669",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115805,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>A) Synchronized DC Cardioversion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the case of a patient presenting with palpitations, narrow complex tachycardia, and hypotension (BP 70/40 mm Hg), the patient is considered hemodynamically unstable. The appropriate management for an unstable patient with a pulse is synchronized DC cardioversion. This intervention is critical to restore normal rhythm promptly and prevent deterioration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Synchronized cardioversion delivers a shock that is timed with the QRS complex, preventing the shock from falling on the T wave, which could induce ventricular fibrillation. This is the standard treatment for unstable supraventricular tachycardia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. IV Adenosine (6mg):</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">IV Adenosine is used for the treatment of stable narrow complex tachycardia. It is not appropriate for an unstable patient due to its transient effect and the need for rapid intervention in unstable conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Carotid Sinus Massage:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Carotid sinus massage is a vagal maneuver used to manage stable narrow complex tachycardia. It is not recommended for unstable patients because it may not be effective quickly enough to stabilize the patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. IV Amiodarone:</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">IV Amiodarone is typically used for stable wide complex tachycardia, especially monomorphic ventricular tachycardia. It is not the first-line treatment for unstable narrow complex tachycardia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In hemodynamically unstable patients with narrow complex tachycardia, synchronized DC cardioversion is the immediate treatment of choice.</span></p>",
      "correct_choice_id": 216497,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54257/INI-CET_May_2024Medicine_Question_2.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54257/INI-CET_May_2024Medicine_Question_2.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54321,
      "choices": [
        {
          "id": 216753,
          "text": "<p><span style=\"font-size:12.0pt;\">Amplification</span></p>"
        },
        {
          "id": 216754,
          "text": "<p><span style=\"font-size:12.0pt;\">Deletion</span></p>"
        },
        {
          "id": 216755,
          "text": "<p><span style=\"font-size:12.0pt;\">Translocation</span></p>"
        },
        {
          "id": 216756,
          "text": "<p><span style=\"font-size:12.0pt;\">Point mutation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">FISH can detect all except which of the following?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q2498174",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115821,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Point mutation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Fluorescence in situ hybridization (FISH) is a cytogenetic technique used to detect and localize specific DNA sequences on chromosomes. It can detect chromosomal abnormalities such as amplifications, deletions, and translocations. However, FISH cannot detect point mutations because these are small-scale changes in DNA sequence that occur at the molecular level, not at the chromosomal level that FISH is designed to analyze.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Amplification:</strong> As FISH can detect gene amplifications, which are increases in the number of copies of a particular gene.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Deletion:</strong> Because FISH can identify chromosomal deletions, where a segment of a chromosome is missing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Translocation:</strong> As FISH is commonly used to detect chromosomal translocations, where segments of chromosomes have exchanged places.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">FISH (Fluorescence in situ hybridization) can detect chromosomal abnormalities like amplifications, deletions, and translocations, but cannot detect point mutations, which require molecular methods such as PCR for identification.</span></p>",
      "correct_choice_id": 216756,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54321/INI-CET_May_2024Medicine_Question_66.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54321/INI-CET_May_2024Medicine_Question_66.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54331,
      "choices": [
        {
          "id": 216793,
          "text": "<p><span style=\"font-size:12.0pt;\">There is no increased risk of colon cancer</span></p>"
        },
        {
          "id": 216794,
          "text": "<p><span style=\"font-size:12.0pt;\">Continuous involvement rather than skip lesions</span></p>"
        },
        {
          "id": 216795,
          "text": "<p><span style=\"font-size:12.0pt;\">Perianal fistulas are frequent</span></p>"
        },
        {
          "id": 216796,
          "text": "<p><span style=\"font-size:12.0pt;\">Seldom manifests with hematochezia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In contrast to Ulcerative Colitis, which of the following statements regarding Crohn's disease is true?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q8013974",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115831,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Perianal fistulas are frequent</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Perianal fistulas are a characteristic feature of Crohn's disease, distinguishing it from ulcerative colitis. This is due to the transmural nature of inflammation in Crohn's disease, which affects all layers of the intestinal wall. Fistulas are a result of this deep tissue involvement and are rarely seen in ulcerative colitis, where inflammation is typically limited to the mucosal layer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. There is no increased risk of colon cancer</strong>: This statement is incorrect. Modern studies show that Crohn's disease patients, especially those with colonic involvement, have a risk of colon cancer comparable to that of ulcerative colitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Continuous involvement rather than skip lesions:</strong> This is incorrect for Crohn's disease. Skip lesions (areas of healthy tissue between inflamed segments) are characteristic of Crohn's disease, while continuous involvement is typical of ulcerative colitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Seldom manifests with hematochezia:</strong> This statement is also incorrect. Patients with Crohn's disease, particularly those with colonic involvement, can manifest with hematochezia (bloody stools), sometimes even regularly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Perianal fistulas are a distinctive feature of Crohn's disease due to its transmural nature, setting it apart from ulcerative colitis where such fistulas are rare.</span></p>",
      "correct_choice_id": 216795,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54331/INI-CET_May_2024Medicine_Question_76.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54331/INI-CET_May_2024Medicine_Question_76.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11868,
      "choices": [
        {
          "id": 47438,
          "text": "<p><span style=\"font-size:12.0pt;\">Metoprolol</span></p>"
        },
        {
          "id": 47439,
          "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
        },
        {
          "id": 47440,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenosine</span></p>"
        },
        {
          "id": 47441,
          "text": "<p><span style=\"font-size:12.0pt;\">Diltiazem</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Based on the ECG given below, which of the following drugs is NOT used in the management of the condition? (INICET NOV 2022)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/whatsapp-image-2024-09-13-at-103835-am.jpeg\" alt=\"\" width=\"300\" height=\"164\"></p>",
      "unique_key": "Q9844721",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115845,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Adenosine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The ECG shows a case of <strong>atrial fibrillation</strong>, characterized by an irregularly irregular rhythm and the absence of distinct P waves. Instead, there are fibrillatory waves that can be seen in the baseline. Atrial fibrillation is a common type of irregular heart rhythm where the atria beat chaotically and irregularly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Adenosine is not used in the management of atrial fibrillation. It is primarily indicated for the treatment of regular narrow complex tachycardias, such as supraventricular tachycardia (SVT). Adenosine works by temporarily blocking the atrioventricular (AV) node, which can help reset the heart rhythm in cases of regular tachycardias. However, in irregular rhythms like atrial fibrillation, adenosine is contraindicated because it can induce atrial fibrillation or exacerbate the condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Metoprolol:</strong> Metoprolol is a beta-blocker used in the management of atrial fibrillation. It helps control the heart rate by slowing down the conduction through the AV node.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Amiodarone:</strong> Amiodarone is an antiarrhythmic medication used for rhythm control in atrial fibrillation. It can help to convert atrial fibrillation to a normal sinus rhythm and maintain it.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Diltiazem:</strong> Diltiazem is a calcium channel blocker used to control the ventricular rate in atrial fibrillation by slowing conduction through the AV node.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Adenosine should not be used in the management of atrial fibrillation due to its potential to induce or worsen the condition.</span></p>",
      "correct_choice_id": 47440,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50947,
      "choices": [
        {
          "id": 203329,
          "text": "<p><span style=\"font-size:12.0pt;\">Total T3&nbsp;</span></p>"
        },
        {
          "id": 203330,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyroid scan&nbsp;</span></p>"
        },
        {
          "id": 203331,
          "text": "<p><span style=\"font-size:12.0pt;\">Free T4&nbsp;</span></p>"
        },
        {
          "id": 203332,
          "text": "<p><span style=\"font-size:12.0pt;\">TSH&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 27-year-old female patient presents with weight loss, anxiety, tachycardia, and restlessness. The resting pulse was 110 beats per minute. Which of the following tests should be done next to evaluate her condition further? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2023</span><span style=\"font-size:12.0pt;\">)</span></p>",
      "unique_key": "Q4137222",
      "question_audio": null,
      "question_video": null,
      "map_id": 35116677,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) TSH</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><span style=\"font-size:10pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\">In the evaluation of suspected thyroid dysfunction, the initial and most crucial test is the measurement of Thyroid-Stimulating Hormone (TSH). TSH is the most sensitive indicator of thyroid function because even minor changes in thyroid hormone levels cause significant changes in TSH levels due to the feedback mechanism between the thyroid gland and the pituitary gland. Elevated or suppressed TSH levels provide clear insight into whether the thyroid gland is underactive (hypothyroidism) or overactive (hyperthyroidism). Given the patient's symptoms of weight loss, anxiety, tachycardia, and restlessness, hyperthyroidism is suspected, making TSH the appropriate initial test.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. &nbsp;Total T3:</strong>&nbsp;T3 levels can be influenced by various factors and are usually measured after initial TSH and Free T4 tests suggest hyperthyroidism.</span></p><p><span style=\"font-size:10pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B. &nbsp;Thyroid Scan:&nbsp;</strong>This imaging test evaluates thyroid structure and function, useful in cases where nodules or hyperactivity need to be assessed. It is not the first-line test for evaluating general thyroid function.</span></p><p><span style=\"font-size:10pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Free T4:&nbsp;</strong>Free T4 is important in assessing thyroid function and is typically measured alongside TSH. However, TSH is preferred as the initial screening test due to its sensitivity in detecting thyroid dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The initial test for evaluating suspected thyroid dysfunction, particularly in hyperthyroid symptoms, is TSH due to its sensitivity and reliability in reflecting thyroid status.</span></p>",
      "correct_choice_id": 203332,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54318,
      "choices": [
        {
          "id": 216741,
          "text": "<p><span style=\"font-size:12.0pt;\">Males and females are equally affected</span></p>"
        },
        {
          "id": 216742,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxidative stress</span></p>"
        },
        {
          "id": 216743,
          "text": "<p><span style=\"font-size:12.0pt;\">Due to deficiency of NADPH</span></p>"
        },
        {
          "id": 216744,
          "text": "<p><span style=\"font-size:12.0pt;\">Characterized by presence of Heinz bodies</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a feature of G6PD deficiency?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q4686933",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115818,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>A) Males and females are equally affected</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">G6PD (Glucose-6-Phosphate Dehydrogenase) deficiency is an X-linked recessive genetic disorder. It is the most common enzyme deficiency worldwide and predominantly affects males. Females can be carriers or, in rare cases, affected if they inherit the defective gene from both parents.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Males and females are equally affected: This statement is incorrect. G6PD deficiency follows an X-linked recessive inheritance pattern, meaning that males are predominantly affected, while females are usually carriers. Thus, males and females are not equally affected.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options :</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Oxidative stress:</strong> G6PD deficiency leads to decreased production of NADPH, which is essential for protecting red blood cells from oxidative damage. The lack of NADPH results in increased oxidative stress within red blood cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Due to deficiency of NADPH:</strong> G6PD is crucial for the pentose phosphate pathway, which generates NADPH. The deficiency of G6PD leads to a shortage of NADPH, impairing the red blood cells' ability to deal with oxidative stress.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Characterized by presence of Heinz bodies:</strong> Heinz bodies are aggregates of denatured hemoglobin found in red blood cells due to oxidative damage. These are characteristic of G6PD deficiency and can be visualized using special stains like new methylene blue.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-140054.jpg\" alt=\"\" width=\"400\" height=\"251\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">G6PD deficiency is an X-linked recessive disorder that predominantly affects males, leads to oxidative stress due to a deficiency of NADPH, and is characterized by the presence of Heinz bodies in red blood cells.</span></p>",
      "correct_choice_id": 216741,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54318/INI-CET_May_2024Medicine_Question_63.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54318/INI-CET_May_2024Medicine_Question_63.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11798,
      "choices": [
        {
          "id": 47158,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Right to left shunt</span></span></p>"
        },
        {
          "id": 47159,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ventilation/Perfusion mismatch</span></span></p>"
        },
        {
          "id": 47160,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypoventilation</span></span></p>"
        },
        {
          "id": 47161,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alveolar membrane damage</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient came with hypoxemia and a normal alveolar-arterial oxygen gradient. What can be the cause? (INICET NOV 2021)</span></span></span></p>",
      "unique_key": "Q8889770",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115834,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Hypoventilation</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypoxemia with a normal alveolar-arterial (A-a) oxygen gradient typically points to specific causes where the alveolar oxygen (PAO2) and arterial oxygen (PaO2) levels remain proportionate. In this scenario, the primary causes are hypoventilation and situations involving low inspired oxygen tension (low FiO2).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Hypoventilation:</span></strong><span style=\"font-size:12.0pt\"> This condition leads to hypoxemia due to inadequate ventilation. When ventilation is insufficient, the amount of oxygen entering the alveoli drops, leading to a corresponding decrease in the amount of oxygen diffusing into the blood, resulting in hypoxemia. However, because the underlying issue is with ventilation and not with oxygen diffusion or blood flow, the A-a gradient remains normal.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Low FiO2 or Low Barometric Pressure:</span></strong><span style=\"font-size:12.0pt\"> This can occur in scenarios such as high altitude where the barometric pressure is low, leading to reduced oxygen availability in the air. However, these situations were not explicitly listed among the answer choices.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">According to the reference paragraph, other conditions like ventilation/perfusion (V/Q) mismatch, diffusion limitation, and alveolar membrane damage, cause an increased A-a gradient due to impaired oxygen transfer across the alveolar membrane or mismatched ventilation and perfusion in the lungs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Right to left shunt:</strong> This condition causes hypoxemia due to blood bypassing the lungs and not getting oxygenated. It leads to an increased A-a gradient because the oxygen content of the arterial blood is significantly lower compared to the alveolar oxygen level.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Ventilation/Perfusion mismatch:</strong> This condition results from areas of the lung receiving oxygen but not perfused with blood or areas perfused with blood but not receiving oxygen. It causes an increased A-a gradient due to ineffective oxygen transfer to the blood.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Alveolar membrane damage:</strong> This results in impaired oxygen diffusion across the alveolar-capillary membrane, leading to an increased A-a gradient as oxygen transfer from alveoli to blood is hindered.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypoventilation is a primary cause of hypoxemia with a normal alveolar-arterial oxygen gradient.</span></span></span></p>",
      "correct_choice_id": 47160,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11799,
      "choices": [
        {
          "id": 47162,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral sumatriptan</span></span></p>"
        },
        {
          "id": 47163,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Subcutaneous sumatriptan</span></span></p>"
        },
        {
          "id": 47164,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">100% oxygen at 6 L/minute</span></span></p>"
        },
        {
          "id": 47165,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">100% oxygen at 8 L/minute</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Treatment of choice for an acute attack of cluster headache is: (INICET NOV 2021)</span></span></span></p>",
      "unique_key": "Q3285611",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115835,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Subcutaneous sumatriptan</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Subcutaneous sumatriptan is shown to be effective in treating acute attacks of cluster headaches. The reference indicates that oral sumatriptan is not effective, whereas subcutaneous sumatriptan has been proven beneficial. I</span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">ntranasal&nbsp;sumatriptan and intranasal zolmitriptan also are shown to be effective.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Additionally, 100% oxygen therapy at a rate of at least 12 liters per minute is effective.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Oral sumatriptan:</span></strong><span style=\"font-size:12.0pt\"> Oral sumatriptan has not been shown to be effective in treating acute cluster headache attacks.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. 100% oxygen at 6 L/minute:</span></strong><span style=\"font-size:12.0pt\"> Although 100% oxygen is a treatment option, the effective rate is at least 12 liters per minute, making 6 L/minute inadequate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. 100% oxygen at 8 L/minute:</span></strong><span style=\"font-size:12.0pt\"> Similar to the previous option, 8 L/minute is below the effective rate of 12 liters per minute required for treating acute cluster headaches.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The treatment of choice for an acute attack of cluster headache is subcutaneous sumatriptan, and 100% oxygen therapy should be administered at a rate of at least 12 liters per minute for effectiveness.</span></span></span></p>",
      "correct_choice_id": 47163,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50955,
      "choices": [
        {
          "id": 203361,
          "text": "<p><span style=\"font-size:12.0pt;\">Anosmia&nbsp;</span></p>"
        },
        {
          "id": 203362,
          "text": "<p><span style=\"font-size:12.0pt;\">Syndactyly in males&nbsp;</span></p>"
        },
        {
          "id": 203363,
          "text": "<p><span style=\"font-size:12.0pt;\">Precocious puberty in females&nbsp;</span></p>"
        },
        {
          "id": 203364,
          "text": "<p><span style=\"font-size:12.0pt;\">White forelock&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the most characteristic feature of Kallmann syndrome? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2023)</span></p>",
      "unique_key": "Q8306528",
      "question_audio": null,
      "question_video": null,
      "map_id": 35116684,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A)&nbsp;Anosmia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Kallmann syndrome is a genetic condition characterized by the failure to start or fully complete puberty and an impaired sense of smell (anosmia). It results from an isolated deficiency of gonadotropin-releasing hormone (GnRH), leading to low levels of follicle-stimulating hormone (FSH) and luteinizing hormone (LH), and consequently, hypogonadotropic hypogonadism. Anosmia is the hallmark feature of Kallmann syndrome and helps differentiate it from other causes of hypogonadotropic hypogonadism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Syndactyly in males:&nbsp;</strong>This refers to the fusion of fingers or toes and is not characteristic of Kallmann syndrome.</span></p><p><span style=\"font-size:10pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Precocious puberty in females:&nbsp;</strong>This is an early onset of puberty, which is not associated with Kallmann syndrome, as this condition causes delayed or absent puberty.</span></p><p><span style=\"font-size:10pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D. White forelock:&nbsp;</strong>This is a feature of Waardenburg syndrome, not Kallmann syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Anosmia is the most characteristic feature of Kallmann syndrome, which is associated with hypogonadotropic hypogonadism due to isolated GnRH deficiency.</span></p>",
      "correct_choice_id": 203361,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11974,
      "choices": [
        {
          "id": 47861,
          "text": "<p><span style=\"font-size:12.0pt;\">Peritoneal Biopsy</span></p>"
        },
        {
          "id": 47862,
          "text": "<p><span style=\"font-size:12.0pt;\">Start ATT</span></p>"
        },
        {
          "id": 47863,
          "text": "<p><span style=\"font-size:12.0pt;\">Observation</span></p>"
        },
        {
          "id": 47864,
          "text": "<p><span style=\"font-size:12.0pt;\">Laparotomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with cough, cold, fever, and malaise associated with weight loss and ascites. The patient does not have any evidence of cirrhosis and her coagulation profile is normal. Ascitic fluid analysis showed elevated adenosine deaminase. What can be done next? (INICET NOV 2022)</span></p>",
      "unique_key": "Q5073104",
      "question_audio": null,
      "question_video": null,
      "map_id": 35116668,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Start ATT</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In countries with a high prevalence of tuberculosis, such as India, the presence of elevated adenosine deaminase (ADA) in ascitic fluid is highly suggestive of abdominal tuberculosis (TB). ADA is a useful diagnostic marker for TB, particularly when its levels are significantly elevated (e.g., above 39 IU/L). Given the clinical context of weight loss, fever, and ascites, along with a high ADA level, it is reasonable to initiate anti-tubercular therapy (ATT) without further invasive testing. Starting ATT and monitoring the patient's response is an effective and practical approach, especially in resource-limited settings. This strategy avoids unnecessary invasive procedures like peritoneal biopsy, which should be reserved for cases where there is doubt about the diagnosis or if the patient does not respond to initial therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Peritoneal Biopsy:</strong> While peritoneal biopsy is the gold standard for diagnosing peritoneal TB, it is invasive and resource-intensive. In high-prevalence areas, where elevated ADA levels strongly suggest TB, initiating ATT is preferred.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Observation:</strong> Given the significant clinical symptoms and elevated ADA levels, mere observation is not appropriate. Delay in treatment could lead to worsening of the patient’s condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Laparotomy:</strong> Laparotomy is an invasive surgical procedure and is not warranted for diagnosing TB when non-invasive methods like ADA testing and clinical presentation strongly suggest the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In high-prevalence countries for tuberculosis, elevated adenosine deaminase (ADA) in ascitic fluid, along with clinical signs, is sufficient to start anti-tubercular therapy (ATT) without the need for invasive procedures.</span></p>",
      "correct_choice_id": 47862,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54307,
      "choices": [
        {
          "id": 216697,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased tone of the pharyngeal muscles worsens obstruction</span></p>"
        },
        {
          "id": 216698,
          "text": "<p><span style=\"font-size:12.0pt;\">Fall of oxygen saturation triggers waking episodes at night</span></p>"
        },
        {
          "id": 216699,
          "text": "<p><span style=\"font-size:12.0pt;\">Episodes of apnea increase stress on the heart</span></p>"
        },
        {
          "id": 216700,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoxemia stimulates respiratory effort</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old male presented to OPD with complaints of excessive daytime sleepiness, and his wife also complains that he snores a lot at night during sleep. Which of the following is incorrect regarding his condition?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q1546565",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115807,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Increased tone of the pharyngeal muscles worsens obstruction</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's symptoms suggest obstructive sleep apnea (OSA), a condition characterized by repeated episodes of partial or complete obstruction of the upper airway during sleep, leading to disrupted sleep and decreased oxygen levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">&nbsp;Increased tone of the pharyngeal muscles worsens obstruction:</span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\">This statement is incorrect. In obstructive sleep apnea, the problem is actually due to the <strong>decreased tone or flaccidity</strong> of the pharyngeal muscles during sleep, which causes the airway to collapse and obstruct. Increased tone of these muscles would actually help keep the airway open.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Fall of oxygen saturation triggers waking episodes at night:</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\">This statement is correct. During episodes of apnea, the blood oxygen levels drop, leading to hypoxemia. This triggers arousal from sleep to restore normal breathing, leading to fragmented sleep and excessive daytime sleepiness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Episodes of apnea increase stress on the heart:</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\">This statement is correct. The repetitive episodes of apnea and hypoxemia increase the work of breathing and intrathoracic pressure changes, which can increase stress on the heart, leading to potential cardiovascular complications such as hypertension and heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hypoxemia stimulates respiratory effort:</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\">This statement is correct. Hypoxemia (low blood oxygen levels) and hypercapnia (high carbon dioxide levels) stimulate the brain's respiratory centers, increasing respiratory effort to overcome the obstruction and restore normal breathing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In obstructive sleep apnea, decreased tone or flaccidity of the pharyngeal muscles during sleep leads to airway collapse and obstruction. Increased muscle tone would help keep the airway open and is not a cause of obstruction in this condition.</span></p>",
      "correct_choice_id": 216697,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54307/INI-CET_May_2024Medicine_Question_52.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54307/INI-CET_May_2024Medicine_Question_52.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11888,
      "choices": [
        {
          "id": 47517,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Piperacillin-Tazobactam</span></span></p>"
        },
        {
          "id": 47518,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amoxicillin-Clavulanate</span></span></p>"
        },
        {
          "id": 47519,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ceftriaxone</span></span></p>"
        },
        {
          "id": 47520,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nitrofurantoin</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient with diabetes develops a UTI, which gets complicated with hypotension that is resistant to IV fluids. Which of the following antibiotics can be used? (INICET NOV 2022)</span></span></span></p>",
      "unique_key": "Q9133877",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115849,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Piperacillin-Tazobactam</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient with diabetes has developed a urinary tract infection (UTI) complicated by hypotension resistant to IV fluids, indicating septic shock. In cases of septic shock, it is critical to start with empirical broad-spectrum antibiotics. These antibiotics are designed to cover a wide range of potential pathogens until the specific causative organism can be identified and targeted.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Broad-spectrum antibiotics suitable for such severe infections include:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Piperacillin-Tazobactam</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Carbapenems like Meropenem or Imipenem</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Certain third-generation cephalosporins like Ceftazidime</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In this case, Piperacillin-Tazobactam is chosen because it is a broad-spectrum antibiotic that covers many of the common pathogens responsible for severe infections and septic shock. Although a combination of Meropenem with Vancomycin would be ideal, the given options do not include Meropenem. Therefore, Piperacillin-Tazobactam is the best choice among the provided options.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Amoxicillin-Clavulanate:</span></strong><span style=\"font-size:12.0pt\"> This antibiotic is generally not sufficient for treating severe infections or septic shock due to its narrower spectrum of activity compared to Piperacillin-Tazobactam.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Ceftriaxone:</span></strong><span style=\"font-size:12.0pt\"> While Ceftriaxone is a third-generation cephalosporin, it is not as broad-spectrum as Ceftazidime and does not provide the same coverage needed for septic shock.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Nitrofurantoin:</span></strong><span style=\"font-size:12.0pt\"> This antibiotic is typically used for uncomplicated lower urinary tract infections and is not effective for severe systemic infections or septic shock.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In the management of septic shock, especially in a patient with diabetes and complicated UTI, broad-spectrum antibiotics such as Piperacillin-Tazobactam are critical for empirical therapy.</span></span></span></p>",
      "correct_choice_id": 47517,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11980,
      "choices": [
        {
          "id": 47885,
          "text": "<p><span style=\"font-size:12.0pt;\">Carboxyhemoglobinemia</span></p>"
        },
        {
          "id": 47886,
          "text": "<p><span style=\"font-size:12.0pt;\">Sideroblastic anemia</span></p>"
        },
        {
          "id": 47887,
          "text": "<p><span style=\"font-size:12.0pt;\">Methemoglobinemia</span></p>"
        },
        {
          "id": 47888,
          "text": "<p><span style=\"font-size:12.0pt;\">Sulfhemoglobinemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female patient presents to the AIIMS emergency department with severe fatigue and prostration. She is a known case of chronic stable angina. While collecting a blood sample, you notice the blood has a brownish hue. What is the underlying diagnosis? (INICET NOV 2022)</span></p>",
      "unique_key": "Q5215309",
      "question_audio": null,
      "question_video": null,
      "map_id": 35116669,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. &nbsp;C) Methemoglobinemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient presenting with a brownish hue in the blood, coupled with a history of chronic stable angina, points towards methemoglobinemia. Patients with chronic stable angina are often on nitrate therapy, which is a known risk factor for developing methemoglobinemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Methemoglobinemia occurs when the iron in hemoglobin is oxidized from the ferrous (Fe²⁺) state to the ferric (Fe³⁺) state, which is unable to bind oxygen effectively. This results in reduced oxygen delivery to tissues, leading to symptoms such as fatigue and cyanosis. The brownish hue of the blood, often described as chocolate-colored, is characteristic of methemoglobinemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Carboxyhemoglobinemia:</strong> Carboxyhemoglobinemia is caused by carbon monoxide poisoning, typically associated with exposure to fire or automobile exhaust. The blood in this condition has a cherry red color, not brownish.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Sideroblastic anemia:</strong> Sideroblastic anemia is a form of anemia where the bone marrow produces ringed sideroblasts rather than healthy red blood cells. It does not cause a brownish hue in the blood.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Sulfhemoglobinemia:</strong> Sulfhemoglobinemia results from the incorporation of sulfur into hemoglobin, leading to a greenish or bluish color of the blood, rather than brownish.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A brownish hue in the blood, especially in a patient on nitrate therapy, is indicative of methemoglobinemia, a condition where hemoglobin is oxidized, impairing its ability to carry oxygen effectively.</span></p>",
      "correct_choice_id": 47887,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11830,
      "choices": [
        {
          "id": 47286,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 only</span></span></p>"
        },
        {
          "id": 47287,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2 and 3</span></span></p>"
        },
        {
          "id": 47288,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2, 3 and 4</span></span></p>"
        },
        {
          "id": 47289,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 2, 3 and 4</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 60-year-old male patient with critical mitral stenosis presented with atrial fibrillation. He has a history of multiple episodes of transient ischemic attacks. Which of the following are true regarding the prevention of stroke in this patient? (INICET NOV 2021)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Only aspirin is given</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Warfarin is given</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Direct oral anticoagulants are not indicated</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mitral valvotomy should be recommended</span></span></span></li>\r\n</ol>",
      "unique_key": "Q6646539",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115840,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) 2 and 3</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For a patient with critical mitral stenosis and atrial fibrillation, particularly one with a history of transient ischemic attacks (TIA), anticoagulation therapy is essential. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">2. Warfarin is the preferred anticoagulant in cases of severe mitral stenosis due to its proven effectiveness in preventing thromboembolic events. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">3. Direct oral anticoagulants (DOACs) are not recommended in this scenario as they are not indicated for patients with moderate to severe mitral stenosis. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1. Aspirin alone is insufficient to prevent stroke in this context. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">4. Mitral valvotomy is not recommended at this point because performing the procedure could dislodge existing clots, leading to embolic events.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In patients with critical mitral stenosis and atrial fibrillation, especially those with a history of TIA, Warfarin should be given for stroke prevention, and direct oral anticoagulants are not indicated.</span></span></span></p>",
      "correct_choice_id": 47287,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50960,
      "choices": [
        {
          "id": 203381,
          "text": "<p><span style=\"font-size:12.0pt;\">Myocardial infarction&nbsp;</span></p>"
        },
        {
          "id": 203382,
          "text": "<p><span style=\"font-size:12.0pt;\">HOCM&nbsp;</span></p>"
        },
        {
          "id": 203383,
          "text": "<p><span style=\"font-size:12.0pt;\">Brugada syndrome&nbsp;</span></p>"
        },
        {
          "id": 203384,
          "text": "<p><span style=\"font-size:12.0pt;\">DCM</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young child presented with nocturnal chest pain and a history of syncope has the ECG shown below. What is the most probable diagnosis? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-112958.png\" alt=\"\" width=\"300\" height=\"182\"></span></p>",
      "unique_key": "Q1536223",
      "question_audio": null,
      "question_video": null,
      "map_id": 35116689,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C)&nbsp;Brugada syndrome</strong></span></p><p><span style=\"font-size:10pt;\">&nbsp;&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">The ECG provided shows the characteristic pattern of Brugada syndrome, which includes:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Pseudo-right bundle branch block pattern in leads V1 and V2.</span></li><li><span style=\"font-size:12.0pt;\">ST-segment elevation in the right precordial leads (V1-V2).</span></li><li><span style=\"font-size:12.0pt;\">Coving of the ST segment.</span></li><li><span style=\"font-size:12.0pt;\">T-wave inversion following the ST-segment elevation.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Brugada syndrome is a genetic disorder that predisposes individuals to ventricular arrhythmias and sudden cardiac death, often occurring at rest or during sleep. It is more prevalent in young males and can present with symptoms such as nocturnal chest pain, syncope, or sudden cardiac arrest.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Myocardial infarction:&nbsp;</strong>Typically presents with ST-segment elevation in contiguous leads but does not usually show the pseudo-right bundle branch block pattern seen in Brugada syndrome.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B. HOCM (Hypertrophic Obstructive Cardiomyopathy):&nbsp;</strong>Characterized by left ventricular hypertrophy and possible left atrial enlargement, often presenting with deep Q waves and signs of left ventricular hypertrophy on ECG, not the specific pattern seen here.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D. DCM (Dilated Cardiomyopathy):&nbsp;</strong>Shows global left ventricular dilation and systolic dysfunction, which can lead to low voltage QRS complexes, left bundle branch block, or non-specific ST-T changes but not the specific Brugada pattern.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Brugada syndrome should be suspected in patients, especially young males, with a history of syncope or nocturnal chest pain presenting with the characteristic ECG pattern of pseudo-right bundle branch block and ST-segment elevation in leads V1 and V2.</span></p>",
      "correct_choice_id": 203383,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54324,
      "choices": [
        {
          "id": 216765,
          "text": "<p><span style=\"font-size:12.0pt;\">High homocysteine and normal methyl malonic acid</span></p>"
        },
        {
          "id": 216766,
          "text": "<p><span style=\"font-size:12.0pt;\">If given at the diagnosis of pregnancy - can prevent neural tube defects</span></p>"
        },
        {
          "id": 216767,
          "text": "<p><span style=\"font-size:12.0pt;\">Folate supplementation is required in children with chronic hemolytic anemia</span></p>"
        },
        {
          "id": 216768,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B12 deficiency should be corrected before supplementing folate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements regarding folate deficiency is FALSE?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q8401471",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115824,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) If given at the diagnosis of pregnancy - can prevent neural tube defects</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The statement in option B is false regarding folate deficiency. Neural tube defects cannot be prevented by administering folic acid at the time of pregnancy diagnosis. Prevention of neural tube defects requires preconceptual folic acid supplementation. When folic acid is given before conception and continued during pregnancy, it can reduce the risk of neural tube defects by approximately 60-70%. Administering folic acid only after pregnancy is diagnosed is too late to prevent these defects, as the neural tube closes very early in embryonic development.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. High homocysteine and normal methyl malonic acid:</strong> This is correct for folate deficiency. High homocysteine is characteristic of folate deficiency, while methyl malonic acid remains normal. Elevated methyl malonic acid is more indicative of B12 deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Folate supplementation is required in children with chronic hemolytic anemia:</strong> This statement is correct. In chronic hemolytic conditions, the increased red blood cell turnover creates a higher demand for folate. Additionally, folate stores in the body are limited, lasting only 3-4 months, necessitating supplementation in these cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Vitamin B12 deficiency should be corrected before supplementing folate:</strong> This is a true statement. In many cases, folate deficiency coexists with B12 deficiency. Treating folate deficiency without addressing B12 deficiency can mask B12 deficiency symptoms and potentially worsen neurological manifestations, even as hematological parameters improve.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Preconceptual folic acid supplementation, not supplementation at pregnancy diagnosis, is crucial for preventing neural tube defects.</span></p>",
      "correct_choice_id": 216766,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54324/INI-CET_May_2024Medicine_Question_69.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54324/INI-CET_May_2024Medicine_Question_69.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50959,
      "choices": [
        {
          "id": 203377,
          "text": "<p><span style=\"font-size:12.0pt;\">i, ii, iii, iv</span></p>"
        },
        {
          "id": 203378,
          "text": "<p><span style=\"font-size:12.0pt;\">i, ii, iii, vi&nbsp;</span></p>"
        },
        {
          "id": 203379,
          "text": "<p><span style=\"font-size:12.0pt;\">i, ii, iii, v&nbsp;</span></p>"
        },
        {
          "id": 203380,
          "text": "<p><span style=\"font-size:12.0pt;\">i, ii, iv, v&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old male presents with increased thirst and increased frequency and volume of urination. He has no other symptoms. His random blood sugar was 205 mg/dl, what appropriate investigations should be done? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2023)</span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-roman;\"><li><span style=\"font-size:12.0pt;\">HbA1c</span></li><li><span style=\"font-size:12.0pt;\">Urine ACR</span></li><li><span style=\"font-size:12.0pt;\">Echocardiography</span></li><li><span style=\"font-size:12.0pt;\">Fundoscopy</span></li><li><span style=\"font-size:12.0pt;\">ECG</span></li><li><span style=\"font-size:12.0pt;\">Serum protein electrophoresis</span></li></ol>",
      "unique_key": "Q1824468",
      "question_audio": null,
      "question_video": null,
      "map_id": 35116688,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D)&nbsp;i, ii, iv, v</strong></span></p><p><span style=\"font-size:10pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">The patient presents with hyperglycemia (random blood sugar of 205 mg/dl), indicating diabetes. The appropriate investigations for a newly diagnosed diabetic patient are:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. HbA1c:&nbsp;</strong>To assess long-term glycemic control and confirm the diagnosis of diabetes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. Urine ACR (Albumin-to-Creatinine Ratio):&nbsp;</strong>To screen for diabetic nephropathy, as microalbuminuria is an early sign of kidney damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Fundoscopy:&nbsp;</strong>To check for diabetic retinopathy and other microvascular changes in the eyes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>5. ECG:&nbsp;</strong>To screen for any cardiovascular complications, as diabetes increases the risk of heart disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Echocardiography</strong>: Not a routine screening test for diabetes unless there is a specific indication, such as suspected heart failure or structural heart disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>6. Serum protein electrophoresis: </strong>Not indicated in the routine evaluation of diabetes and is used to diagnose conditions like multiple myeloma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For a newly diagnosed diabetic patient, essential investigations include HbA1c, urine ACR, fundoscopy, and ECG to assess glycemic control, kidney function, eye health, and cardiovascular risk, respectively.</span></p>",
      "correct_choice_id": 203380,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54319,
      "choices": [
        {
          "id": 216745,
          "text": "<p><span style=\"font-size:12.0pt;\">Nodular sclerosis is the most common and involves the mediastinum</span></p>"
        },
        {
          "id": 216746,
          "text": "<p><span style=\"font-size:12.0pt;\">Waldeyer's ring is commonly involved</span></p>"
        },
        {
          "id": 216747,
          "text": "<p><span style=\"font-size:12.0pt;\">CD15 &amp; CD30 positivity in Reed Sternberg cells</span></p>"
        },
        {
          "id": 216748,
          "text": "<p><span style=\"font-size:12.0pt;\">Reed Sternberg cells are derived from B cells</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is/are incorrect about Hodgkin's lymphoma?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q7853805",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115819,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Waldeyer’s ring is commonly involved</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The statement that Waldeyer's ring is commonly involved in Hodgkin's lymphoma is incorrect. In classic Hodgkin's lymphoma, involvement of Waldeyer's ring and mesenteric nodes is very unlikely. This is typically seen in non-Hodgkin's lymphoma, not in classic Hodgkin's lymphoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Nodular sclerosis is the most common and involves the</strong> <strong>mediastinum:</strong> This is correct. Nodular sclerosis is indeed the most common histological type of Hodgkin's lymphoma worldwide, and it typically involves the mediastinum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. CD15 &amp; CD30 positivity in Reed Sternberg cells:</strong> This is correct. CD15 and CD30 positivity is a classic feature of Reed Sternberg cells in Hodgkin's lymphoma. In fact, this characteristic is exploited in targeted therapy, such as the use of Brentuximab-Vedotin, an antibody-drug conjugate against CD30, for refractory classic Hodgkin's lymphoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Reed Sternberg cells are derived from B cells:</strong> This is correct. Reed Sternberg cells are indeed derived from B cells, specifically from \"crippled\" B cells in the lymph node.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In classic Hodgkin's lymphoma, Waldeyer's ring involvement is uncommon, unlike in non-Hodgkin's lymphoma. The disease typically involves the mediastinum, with nodular sclerosis being the most common histological type.</span></p>",
      "correct_choice_id": 216746,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54319/INI-CET_May_2024Medicine_Question_64.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54319/INI-CET_May_2024Medicine_Question_64.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54325,
      "choices": [
        {
          "id": 216769,
          "text": "<p><span style=\"font-size:12.0pt;\">Cola coloured urine Occurs &gt; 2 hours</span></p>"
        },
        {
          "id": 216770,
          "text": "<p><span style=\"font-size:12.0pt;\">Failure of Hb to rise</span></p>"
        },
        {
          "id": 216771,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased Indirect Bilirubin</span></p>"
        },
        {
          "id": 216772,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased S. LDH</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient undergoes PRBC transfusion. Which of the following is incorrect with regards to Delayed Hemolytic Transfusion Reaction?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q6588046",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115825,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Cola coloured urine Occurs &gt; 2 hours</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a Delayed Hemolytic Transfusion Reaction (DHTR), symptoms typically appear after 24 hours of transfusion, sometimes even days or weeks later. The statement that cola-colored urine occurs &gt; 2 hours is incorrect for DHTR. This dark urine, indicative of hemoglobinuria due to intravascular hemolysis, is a characteristic feature of DHTR but occurs much later than 2 hours post-transfusion. In DHTR, the hemolysis is delayed because it takes time for the patient's immune system to mount a secondary response to the transfused red blood cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Failure of Hb to rise:</strong> This is correct for DHTR. Despite transfusion, the hemoglobin level does not increase as expected due to the destruction of transfused red blood cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Increased Indirect Bilirubin:</strong> This is correct. As red blood cells are destroyed in DHTR, there's an increase in indirect bilirubin, a byproduct of hemoglobin breakdown.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Increased S. LDH:</strong> This is correct. Serum lactate dehydrogenase (LDH) levels increase in DHTR due to the release of this enzyme from lysed red blood cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In Delayed Hemolytic Transfusion Reaction, symptoms including cola-colored urine appear after 24 hours of transfusion, not within 2 hours.</span></p>",
      "correct_choice_id": 216769,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54325/INI-CET_May_2024Medicine_Question_70.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54325/INI-CET_May_2024Medicine_Question_70.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11790,
      "choices": [
        {
          "id": 47126,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bartter syndrome</span></span></p>"
        },
        {
          "id": 47127,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liddle syndrome</span></span></p>"
        },
        {
          "id": 47128,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gitelman syndrome</span></span></p>"
        },
        {
          "id": 47129,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gordon syndrome</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following conditions is associated with hypokalemic metabolic alkalosis with hypertension? (INICET NOV 2021)</span></span></span></p>",
      "unique_key": "Q4585263",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115832,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Liddle syndrome</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Liddle syndrome is a genetic disorder characterized by the overactivation of the epithelial sodium channels (ENaC) in the principal cells of the kidneys. This overactivation is due to a gain-of-function mutation in the genes encoding these channels. The increased activity of ENaC leads to excessive reabsorption of sodium and water, causing hypertension. Concurrently, there is increased excretion of potassium and hydrogen ions, which results in hypokalemia and metabolic alkalosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This condition is often referred to as<strong> pseudo-hyperaldosteronism</strong> because it mimics the effects of aldosterone but without elevated aldosterone levels. The treatment of choice for Liddle syndrome is amiloride, which directly inhibits ENaC channels, unlike spironolactone, which is ineffective in this condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Bartter syndrome:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Bartter syndrome also presents with hypokalemia and metabolic alkalosis, but patients typically have normal blood pressure. It is a group of autosomal recessive disorders that affect the thick ascending limb of the loop of Henle, mimicking the effects of loop diuretics. Symptoms often present in childhood and may include polyuria, polydipsia, and growth delays. Additionally, patients might have nephrocalcinosis due to increase urinary calcium, recurrent urinary stones, and sometimes sensorineural deafness.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Gitelman syndrome:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Gitelman syndrome, like Bartter syndrome, involves hypokalemia and metabolic alkalosis with normal blood pressure. It affects the distal convoluted tubule of the kidney, similar to the action of thiazide diuretics. Patients usually present in adulthood with symptoms such as muscle weakness, cramps, and <strong>tetany due to hypomagnesemia</strong>, which is a significant feature distinguishing it from Bartter syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Gordon syndrome:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Gordon syndrome, or <strong>pseudohypoaldosteronism</strong> type II, is characterized by hypertension and <strong>hyperkalemia, along with metabolic acidosis,</strong> not alkalosis. It results from mutations leading to increased sodium chloride reabsorption in the distal convoluted tubule. Unlike Liddle syndrome, patients with Gordon syndrome exhibit hyperkalemia and acidosis due to chloride retention.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Liddle syndrome is characterized by hypokalemic metabolic alkalosis and hypertension due to the overactivation of epithelial sodium channels in the kidneys.</span></span></span></p>",
      "correct_choice_id": 47127,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54278,
      "choices": [
        {
          "id": 216581,
          "text": "<p><span style=\"font-size:12.0pt;\">Risedronate</span></p>"
        },
        {
          "id": 216582,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcitriol</span></p>"
        },
        {
          "id": 216583,
          "text": "<p><span style=\"font-size:12.0pt;\">Lithium</span></p>"
        },
        {
          "id": 216584,
          "text": "<p><span style=\"font-size:12.0pt;\">Diuretics</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following drugs decreases the serum parathyroid hormone levels?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q1334958",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115803,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Calcitriol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Calcitriol is the active form of vitamin D and plays a crucial role in calcium and phosphate metabolism in the body. It directly acts on vitamin D receptors (VDRs) present in the parathyroid gland, leading to a decrease in the secretion of parathyroid hormone (PTH).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mechanism of Action:</strong> Calcitriol increases the absorption of calcium and phosphate from the intestines. Elevated levels of calcium in the blood provide negative feedback to the parathyroid glands, which reduces the production of PTH. Additionally, calcitriol directly inhibits the synthesis and secretion of PTH by binding to VDRs in the parathyroid gland. This dual action ensures a reduction in PTH levels, making calcitriol an effective treatment for conditions associated with secondary hyperparathyroidism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Note - <strong>Paricalcitol</strong>: A synthetic vitamin D receptor (VDR) agonist used to reduce PTH levels in primary hyperparathyroidism. This drug is related to the <strong>Cinacalcet</strong>, a calcium sensitizer but this act on the calcium-sensing receptor (CaSR).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Risedronate:</strong> Risedronate is a bisphosphonate used to treat osteoporosis. It works by inhibiting osteoclast-mediated bone resorption, which can sometimes lead to hypocalcemia. Hypocalcemia can reflexively increase PTH levels, rather than decrease them.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Lithium:</strong> Lithium is known to cause unexplained hyperparathyroidism and consequently increase PTH levels. It is one of the common causes of unexplained hyperparathyroidism, making it an unsuitable option for decreasing PTH levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Diuretics:</strong> Diuretics, particularly loop diuretics, can cause hypocalcemia, which in turn can lead to an increase in PTH levels. Thiazide diuretics can cause hypercalcemia, which might decrease PTH levels, but in this question, \"diuretics\" is mentioned generally, and loop diuretics are more commonly associated with increased PTH levels due to hypocalcemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Calcitriol, the active form of vitamin D, decreases serum parathyroid hormone levels by increasing calcium absorption from the intestines and directly inhibiting PTH secretion from the parathyroid glands through its action on vitamin D receptors.</span></p>",
      "correct_choice_id": 216582,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54278/INI-CET_May_2024Medicine_Question_23.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54278/INI-CET_May_2024Medicine_Question_23.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50956,
      "choices": [
        {
          "id": 203365,
          "text": "<p><span style=\"font-size:12.0pt;\">Severe acidosis with elevated BUN and creatinine&nbsp;</span></p>"
        },
        {
          "id": 203366,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypertension</span></p>"
        },
        {
          "id": 203367,
          "text": "<p><span style=\"font-size:12.0pt;\">Potassium level of 6 mEq/L&nbsp;</span></p>"
        },
        {
          "id": 203368,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic alkalosis&nbsp;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with CKD with refractory hypertension is brought to the casualty with dizziness. His BP was found to be 200/120 mmHg. His BUN was 50 mg/dl and creatinine was 3 mg/dl. Potassium was 6 mEq/L. Which of the following is an indication of emergency hemodialysis? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2023)</span></p>",
      "unique_key": "Q2425441",
      "question_audio": null,
      "question_video": null,
      "map_id": 35116685,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A)&nbsp;Severe acidosis with elevated BUN and creatinine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Emergency hemodialysis is indicated in several critical conditions commonly remembered with the mnemonic AEIOU:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Acidosis: Severe metabolic acidosis that is not responsive to standard medical therapy, particularly when the pH is less than 7.1.</span></li><li><span style=\"font-size:12.0pt;\">Electrolyte imbalance: Severe hyperkalemia, especially when potassium levels are more than 6.5 mEq/L, rapidly rising, or refractory to medical management.</span></li><li><span style=\"font-size:12.0pt;\">Intoxications: With dialyzable drugs.</span></li><li><span style=\"font-size:12.0pt;\">Overload: Volume overload state, such as diuretic-resistant pulmonary edema, particularly when oxygen requirements are increasing.</span></li><li><span style=\"font-size:12.0pt;\">Uremia: Uremic complications such as pericarditis or encephalopathy, which are urgent indications due to the risk of tamponade or severe cognitive impairment.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this patient, severe acidosis, alongside elevated BUN and creatinine, is a strong indication for emergency hemodialysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hypertension:&nbsp;</strong>Hypertension alone, even when severe, is not an immediate indication for emergency hemodialysis</span></p><p><span style=\"font-size:10pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Potassium level of 6 mEq/L:&nbsp;</strong>While elevated, a potassium level of 6 mEq/L by itself is not enough to indicate emergency dialysis unless it is rapidly rising or refractory to treatment. Typically, levels above 6.5 mEq/L are considered more critical.</span></p><p><span style=\"font-size:10pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Metabolic alkalosis:&nbsp;</strong>This is not an indication for emergency hemodialysis. Instead, metabolic acidosis, especially when severe and refractory to treatment, is a more significant concern.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Emergency hemodialysis is indicated for severe acidosis, refractory hyperkalemia, volume overload, intoxications, and uremic complications. Severe acidosis with elevated BUN and creatinine is a critical indication for initiating emergency hemodialysis.</span></p>",
      "correct_choice_id": 203365,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54309,
      "choices": [
        {
          "id": 216705,
          "text": "<p><span style=\"font-size:12.0pt;\">Sugammadex</span></p>"
        },
        {
          "id": 216706,
          "text": "<p><span style=\"font-size:12.0pt;\">Neostigmine</span></p>"
        },
        {
          "id": 216707,
          "text": "<p><span style=\"font-size:12.0pt;\">Edrophonium</span></p>"
        },
        {
          "id": 216708,
          "text": "<p><span style=\"font-size:12.0pt;\">Atropine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old male underwent surgery with rocuronium as a muscle relaxant and has not regained muscle function post-surgery. Which of the following can result in the fastest reversal?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q3912797",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115809,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Sugammadex</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Rocuronium is a non-depolarizing neuromuscular blocking agent commonly used during surgery to induce muscle relaxation. After surgery, the reversal of its effects is crucial to restore muscle function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Sugammadex</strong> is a selective relaxant binding agent specifically designed to encapsulate and inactivate rocuronium and vecuronium. Sugammadex rapidly reverses the effects of these muscle relaxants by forming a tight complex with the drug, thereby preventing it from binding to nicotinic receptors. This results in the fastest reversal of neuromuscular blockade caused by rocuronium.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note</strong> – A new drug called <strong>calabadion</strong> is a broad-spectrum that can be used for the reversal of every single neuromuscular blocking agent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Neostigmine</strong>: An acetylcholinesterase inhibitor that increases the concentration of acetylcholine at the neuromuscular junction, thus competing with non-depolarizing muscle relaxants like rocuronium. However, its action is not as rapid as sugammadex and is generally used for a broader range of non-depolarizing neuromuscular blockers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Edrophonium</strong>: Another acetylcholinesterase inhibitor used primarily in the diagnosis of myasthenia gravis rather than for reversing neuromuscular blockade in surgical settings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Atropine</strong>: An anticholinergic drug that does not have any role in reversing neuromuscular blockade</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">as it targets muscarinic receptors. It is used to counteract bradycardia and to reduce salivation during surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sugammadex is the fastest and most specific agent for reversing the effects of rocuronium by directly encapsulating the drug and preventing its action at the neuromuscular junction.</span></p>",
      "correct_choice_id": 216705,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54309/INI-CET_May_2024Medicine_Question_54.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54309/INI-CET_May_2024Medicine_Question_54.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54323,
      "choices": [
        {
          "id": 216761,
          "text": "<p><span style=\"font-size:12.0pt;\">IgM is the most common antibody in ABO</span></p>"
        },
        {
          "id": 216762,
          "text": "<p><span style=\"font-size:12.0pt;\">ABO antibodies are natural and present since birth</span></p>"
        },
        {
          "id": 216763,
          "text": "<p><span style=\"font-size:12.0pt;\">ABO antigens are carbohydrates</span></p>"
        },
        {
          "id": 216764,
          "text": "<p><span style=\"font-size:12.0pt;\">Antibodies are present only if antigens are absent</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Regarding ABO blood grouping, which statement is false?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q4898666",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115823,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) ABO antibodies are natural and present since birth</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The statement \"ABO antibodies are natural and present since birth\" is false. While ABO antibodies are indeed considered natural antibodies, they are not present at birth. These antibodies develop through a process called molecular mimicry after exposure to gut commensals. Typically, ABO antibodies begin to appear around 3 to 6 months of age, not immediately after birth as the statement suggests.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. IgM is the most common antibody in ABO:</strong> This statement is correct. IgM is the predominant antibody type in the ABO blood group system. This characteristic is important because IgM antibodies, due to their large size, cannot cross the placenta, which is crucial for preventing complications during pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. ABO antigens are carbohydrates:</strong> &nbsp;This statement is correct. ABO antigens are oligosaccharides, which are carbohydrate structures. This fact has been established and discussed multiple times in the context of blood group antigens.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Antibodies are present only if antigens are absent:</strong> This statement is also correct. In the ABO blood group system, an individual's blood will contain antibodies against the ABO antigens that are not present on their own red blood cells. This principle is fundamental to understanding ABO blood group compatibility.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">ABO antibodies, while natural, are not present at birth but develop in the first few months of life (typically 3-6 months) through exposure to environmental factors, particularly gut bacteria.</span></p>",
      "correct_choice_id": 216762,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54323/INI-CET_May_2024Medicine_Question_68.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54323/INI-CET_May_2024Medicine_Question_68.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54314,
      "choices": [
        {
          "id": 216725,
          "text": "<p><span style=\"font-size:12.0pt;\">Achalasia cardia</span></p>"
        },
        {
          "id": 216726,
          "text": "<p><span style=\"font-size:12.0pt;\">Esophageal carcinoma</span></p>"
        },
        {
          "id": 216727,
          "text": "<p><span style=\"font-size:12.0pt;\">Zenker's diverticulum</span></p>"
        },
        {
          "id": 216728,
          "text": "<p><span style=\"font-size:12.0pt;\">Diffuse esophageal spasm</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old patient presents with regurgitation of food and weight loss over the past several months. A barium swallow is performed. What is the likely diagnosis?</span>&nbsp;(INICET MAY 2024)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-134638.jpg\" alt=\"\" width=\"300\" height=\"490\"></span></p>",
      "unique_key": "Q5720867",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115814,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Achalasia cardia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient presents with symptoms of regurgitation and weight loss, and a barium swallow shows a characteristic \"bird's beak\" appearance. This finding is highly suggestive of achalasia cardia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Achalasia cardia</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">is characterized by the failure of the lower esophageal sphincter to relax, leading to a functional obstruction of the esophagus. The classic radiographic feature seen on a barium swallow is a smooth, tapered narrowing at the lower esophagus resembling a bird's beak. Symptoms include progressive dysphagia, regurgitation of undigested food, and weight loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Esophageal carcinoma</strong>: While esophageal carcinoma can present with similar symptoms, it typically occurs in older patients (50yr+) and may produce a similar radiographic appearance, known as \"pseudoachalasia.\" However, the age of the patient and the classic bird's beak appearance make achalasia the more likely diagnosis in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Zenker's diverticulum</strong>: This condition involves the formation of a diverticulum in the hypopharynx, leading to symptoms such as dysphagia, regurgitation, and halitosis. The radiographic appearance is different, typically showing a pouch at the back of the throat, rather than the bird's beak seen in achalasia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Diffuse esophageal spasm</strong>: This condition presents with intermittent dysphagia and chest pain. The barium swallow typically shows a corkscrew esophagus due to simultaneous, uncoordinated contractions, which is distinct from the bird's beak appearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Achalasia cardia is characterized by the failure of the lower esophageal sphincter to relax, leading to a bird's beak appearance on a barium swallow. This is the most likely diagnosis in a patient presenting with regurgitation of food and weight loss.</span></p>",
      "correct_choice_id": 216725,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54314/INI-CET_May_2024Medicine_Question_59.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54314/INI-CET_May_2024Medicine_Question_59.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11994,
      "choices": [
        {
          "id": 47941,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pneumoperitoneum</span></span></p>"
        },
        {
          "id": 47942,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pneumopericardium</span></span></p>"
        },
        {
          "id": 47943,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pneumomediastinum</span></span></p>"
        },
        {
          "id": 47944,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydropneumothorax</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hamman sign is seen in: (INICET NOV 2022)</span></span></span></p>",
      "unique_key": "Q5471095",
      "question_audio": null,
      "question_video": null,
      "map_id": 35116672,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. &nbsp;C) Pneumomediastinum</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hamman sign, also known as Hamman&#39;s mediastinal crunch, is a crunching, rasping sound, synchronous with the heartbeat, heard over the precordium in cases of pneumomediastinum. This sign is caused by air in the mediastinum, which is the central compartment of the thoracic cavity. The presence of air in this area leads to a characteristic sound as the heart beats, which can be heard on auscultation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Pneumoperitoneum:</span></strong><span style=\"font-size:12.0pt\"> Pneumoperitoneum refers to the presence of air within the peritoneal cavity, usually due to gastrointestinal perforation. Clinical signs include guarding, rigidity, and air under the diaphragm visible on imaging. Hamman sign is not associated with pneumoperitoneum.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Pneumopericardium:</span></strong><span style=\"font-size:12.0pt\"> This condition involves air within the pericardial cavity surrounding the heart. While it can cause similar auscultatory findings, it does not specifically present with Hamman sign.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hydropneumothorax:</span></strong><span style=\"font-size:12.0pt\"> This condition involves both air and fluid in the pleural space. A significant clinical finding here is straight-line dullness on percussion, not Hamman sign.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hamman sign, or Hamman&#39;s crunch, is a specific clinical sign heard in cases of pneumomediastinum, characterized by a crunching sound synchronous with the heartbeat due to the presence of air in the mediastinum.</span></span></span></p>",
      "correct_choice_id": 47943,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54329,
      "choices": [
        {
          "id": 216785,
          "text": "<p><span style=\"font-size:12.0pt;\">NS1 antigen test</span></p>"
        },
        {
          "id": 216786,
          "text": "<p><span style=\"font-size:12.0pt;\">Viral culture</span></p>"
        },
        {
          "id": 216787,
          "text": "<p><span style=\"font-size:12.0pt;\">PCR</span></p>"
        },
        {
          "id": 216788,
          "text": "<p><span style=\"font-size:12.0pt;\">IgM ELISA</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with fever for 5 days and retro-orbital pain, suggestive of dengue fever. Which investigation should be conducted next for confirmation?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q5783579",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115829,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) IgM ELISA</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For a patient presenting with symptoms suggestive of dengue fever for 5 days, the most appropriate test for confirmation is IgM ELISA. According to national dengue guidelines, NS1 antigen testing is most effective in the first 1-4 days of illness. However, from day 5 onwards, IgM antibodies become detectable, making IgM ELISA the preferred test for confirmation at this stage of the illness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. NS1 antigen test:</strong> While useful for early detection (days 1-4), it's less effective after 5 days of symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Viral culture:</strong> Though it can be used for dengue diagnosis, it's not the preferred method due to time constraints and complexity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. PCR:</strong> While sensitive, PCR is most useful in the early stages of infection and may not be the best choice after 5 days of symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For dengue fever confirmation after 5 days of symptoms, IgM ELISA is the most appropriate diagnostic test according to national guidelines.</span></p>",
      "correct_choice_id": 216788,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54329/INI-CET_May_2024Medicine_Question_74.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54329/INI-CET_May_2024Medicine_Question_74.mp4",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11998,
      "choices": [
        {
          "id": 47956,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 2</span></p>"
        },
        {
          "id": 47957,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 4</span></p>"
        },
        {
          "id": 47958,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3</span></p>"
        },
        {
          "id": 47959,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following are signs of heart failure? (INICET NOV 2022)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Non-pulsatile rise of JVP</span></li><li><span style=\"font-size:12.0pt;\">Orthopnea</span></li><li><span style=\"font-size:12.0pt;\">Dyspnea after 2 hours of sleep</span></li><li><span style=\"font-size:12.0pt;\">Right upper quadrant pain/Right hypochondrial pain</span></li></ol>",
      "unique_key": "Q8333240",
      "question_audio": null,
      "question_video": null,
      "map_id": 35116673,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 2, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Heart failure presents with a range of symptoms due to the inability of the heart to pump blood effectively. The following signs are indicative of heart failure:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Orthopnea (Option 2):</strong> This is difficulty breathing when lying flat and is a common symptom of left-sided heart failure.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Dyspnea after 2 hours of sleep (Option 3):</strong> Also known as paroxysmal nocturnal dyspnea (PND), this occurs due to fluid redistribution during sleep, leading to pulmonary congestion.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Right upper quadrant pain/Right hypochondrial pain (Option 4):</strong> This is associated with right-sided heart failure leading to congestive hepatomegaly.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option 1 (Non-pulsatile rise of JVP):</strong> This is incorrect as heart failure typically causes a pulsatile rise in jugular venous pressure (JVP). A non-pulsatile rise in JVP is usually indicative of superior vena cava (SVC) obstruction, not heart failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Signs of heart failure include orthopnea, paroxysmal nocturnal dyspnea (PND), and right upper quadrant pain due to congestive hepatomegaly.</span></p>",
      "correct_choice_id": 47957,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50954,
      "choices": [
        {
          "id": 203357,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chest wall neuromuscular disease&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203358,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sarcoidosis&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203359,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Idiopathic pulmonary fibrosis&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 203360,
          "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchiectasis&nbsp;</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given image shows a normal graph on the left and the patient&#39;s graph on the right. Which of the following diagnoses can be inferred from the graph? (</span></span></span></span>INICET Nov 2023)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-112354.png\" style=\"height:188px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q8251401",
      "question_audio": null,
      "question_video": null,
      "map_id": 35116683,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></span></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bronchiectasis</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: &nbsp;</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The spirometry graph compares a normal patient&#39;s lung function with that of the patient. The normal graph shows an FEV1/FVC ratio (Forced Expiratory Volume in 1 second / Forced Vital Capacity) of more than 70%, which is typical in healthy individuals. In contrast, the patient&#39;s graph shows a significantly reduced FEV1/FVC ratio of approximately 50-55%, indicating an obstructive lung disease. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Obstructive lung diseases are characterized by reduced airflow due to airway narrowing or obstruction, leading to a lower FEV1/FVC ratio. The common obstructive lung diseases include asthma, emphysema, chronic bronchitis, COPD, bronchiectasis, and cystic fibrosis. Among the given options, bronchiectasis is the only obstructive lung disease.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Chest wall neuromuscular disease:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This typically causes restrictive lung disease, not obstructive, and would present with a normal or high FEV1/FVC ratio but reduced lung volumes.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Sarcoidosis:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is an interstitial lung disease, which is restrictive. It would show a normal or elevated FEV1/FVC ratio with reduced lung volumes.</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">&nbsp; </span></span></p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Idiopathic pulmonary fibrosis:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Another interstitial lung disease leading to restrictive patterns on spirometry, characterized by a normal or high FEV1/FVC ratio with reduced total lung capacity.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A reduced FEV1/FVC ratio (&lt;70%) is indicative of obstructive lung disease. Among the given options, bronchiectasis is the obstructive lung disease associated with this spirometry pattern.</span></span></p>",
      "correct_choice_id": 203360,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54308,
      "choices": [
        {
          "id": 216701,
          "text": "<p><span style=\"font-size:12.0pt;\">Syrup Dextromethorphan with bromhexine</span></p>"
        },
        {
          "id": 216702,
          "text": "<p><span style=\"font-size:12.0pt;\">Syrup Codeine</span></p>"
        },
        {
          "id": 216703,
          "text": "<p><span style=\"font-size:12.0pt;\">Syrup Dextromethorphan</span></p>"
        },
        {
          "id": 216704,
          "text": "<p><span style=\"font-size:12.0pt;\">Syrup Bromhexine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old patient presents with fever, cough, and tenacious white sputum. Which of the following should be used for treatment?</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q4403059",
      "question_audio": null,
      "question_video": null,
      "map_id": 35115808,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>D) Syrup Bromhexine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient presents with a productive cough characterized by tenacious white sputum. In such cases, it is essential to use a treatment that helps break down and clear the mucus to prevent further complications like infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Syrup Bromhexine</strong> is a mucolytic agent that works by breaking down mucus, making it easier to clear from the respiratory tract. This is the most appropriate treatment for a patient with thick, tenacious sputum as it will help in liquefying the mucus and promoting its expulsion through coughing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Syrup Dextromethorphan with bromhexine:</strong> This combination does not make sense therapeutically. Dextromethorphan is an antitussive, which suppresses cough, while bromhexine is a mucolytic, which helps break down mucus. Using them together is illogical because you do not want to suppress the cough when the patient has productive sputum that needs to be expelled.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Syrup Codeine:</strong> Codeine is also an antitussive and should not be used in patients with productive cough. Suppressing the cough can lead to accumulation of sputum, which can cause infections.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Syrup Dextromethorphan:</strong> Similar to codeine, dextromethorphan is an antitussive and is not appropriate for treating a productive cough. It will suppress the cough reflex, leading to retention of mucus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In patients with a productive cough and thick, tenacious sputum, mucolytic agents like bromhexine should be used to help break down and clear the mucus, rather than suppressing the cough reflex with antitussives.</span></p>",
      "correct_choice_id": 216704,
      "solution_audio": null,
      "solution_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54308/INI-CET_May_2024Medicine_Question_53.mp4",
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "top",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": "https://media.cerebellumacademy.com/media/public/question_media/solution/video/54308/INI-CET_May_2024Medicine_Question_53.mp4",
      "question_images": [],
      "explanation_images": []
    }
  ]
}